10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2023

or

☐ TRANSITION REPORT PURSUANT TO Section 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 001-39735

The Beachbody Company, Inc.

(Exact name of registrant as specified in its charter)

Delaware	85-3222090
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
400 Continental Blvd, Suite 400 El Segundo, California	90245
(Address of principal executive offices)	(Zip Code)

(310) 883-9000

Registrant’s telephone number, including area code

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Class A Common Stock, par value $0.0001 per share	BODY	The New York Stock Exchange
Redeemable warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50	BODY WS	The New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer ☐ Accelerated Filer ☒ Non-Accelerated Filer ☐ Smaller Reporting Company ☒ Emerging Growth Company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒

There were 177,193,226 shares of the registrant’s Class A Common Stock, par value $0.0001 per share, and 141,250,310 shares of the registrant’s Class X Common Stock, par value $0.0001 per share, outstanding as of May 02, 2023.

Table of Contents

Part I.	Financial Information	3
Item 1.	Financial Statements	3
	Condensed Consolidated Balance Sheets	3
	Unaudited Condensed Consolidated Statements of Operations	4
	Unaudited Condensed Consolidated Statements of Comprehensive Loss	5
	Unaudited Condensed Consolidated Statements of Stockholders’ Equity	6
	Unaudited Condensed Consolidated Statements of Cash Flows	7
	Notes to Unaudited Condensed Consolidated Financial Statements	8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Operations	20
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	31
Item 4.	Controls and Procedures	31
Part II.	Other Information	31
Item 1.	Legal Proceedings	31
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	32
Item 3.	Defaults Upon Senior Securities	32
Item 4.	Mine Safety Disclosures	32
Item 5.	Other Information	32
Item 6.	Exhibits	33
Signatures		34

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements.

The Beachbody Company, Inc.

Condensed Consolidated Balance Sheets

(in thousands, except share and per share data)

	March 31,			December 31,
	2023			2022
	(unaudited)
Assets
Current assets:
Cash and cash equivalents	$	66,393		$	80,091
Inventory, net		48,304			54,060
Prepaid expenses		11,403			13,055
Other current assets		45,687			39,248
Total current assets		171,787			186,454
Property and equipment, net		67,395			74,147
Content assets, net		31,551			34,888
Goodwill		125,166			125,166
Intangible assets, net		6,926			8,204
Right-of-use assets, net		4,520			5,030
Other assets		8,428			9,506
Total assets	$	415,773		$	443,395
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable	$	16,754		$	17,940
Accrued expenses		54,784			64,430
Deferred revenue		99,894			95,587
Current portion of lease liabilities		2,100			2,150
Current portion of Term Loan		1,250			1,250
Other current liabilities		3,513			3,283
Total current liabilities		178,295			184,640
Term Loan		40,276			39,735
Long-term lease liabilities, net		2,794			3,318
Deferred tax liabilities		172			181
Other liabilities		4,679			3,979
Total liabilities		226,216			231,853
Commitments and contingencies (Note 8)
Stockholders’ equity:
Preferred stock, $0.0001 par value; 100,000,000 shares    authorized, none issued and outstanding at March 31, 2023    and December 31, 2022		—			—
Common stock, $0.0001 par value, 1,900,000,000 shares    authorized (1,600,000,000 Class A, 200,000,000 Class X and    100,000,000 Class C);
Class A: 177,004,131 and 170,911,819 shares issued and     outstanding at March 31, 2023 and December 31,     2022, respectively;		18			17
Class X: 141,250,310 shares issued and outstanding at     March 31, 2023 and December 31, 2022, respectively;		14			14
Class C: no shares issued and outstanding at    March 31, 2023 and December 31, 2022		—			—
Additional paid-in capital		638,135			630,709
Accumulated deficit		(448,423	)		(419,235	)
Accumulated other comprehensive income (loss)		(187	)		37
Total stockholders’ equity		189,557			211,542
Total liabilities and stockholders’ equity	$	415,773		$	443,395

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

3

The Beachbody Company, Inc.

Unaudited Condensed Consolidated Statements of Operations

(in thousands, except per share data)

	Three months ended March 31,
	2023			2022
Revenue:
Digital	$	64,773		$	81,745
Nutrition and other		74,120			97,664
Connected fitness		6,008			19,513
Total revenue		144,901			198,922
Cost of revenue:
Digital		14,967			16,425
Nutrition and other		31,039			44,774
Connected fitness		7,555			44,706
Total cost of revenue		53,561			105,905
Gross profit		91,340			93,017
Operating expenses:
Selling and marketing		76,576			106,444
Enterprise technology and development		19,096			33,697
General and administrative		17,716			20,073
Restructuring		5,387			7,223
Total operating expenses		118,775			167,437
Operating loss		(27,435	)		(74,420	)
Other income (expense):
Change in fair value of warrant liabilities		57			264
Interest expense		(2,331	)		(19	)
Other income (expense), net		569			(64	)
Loss before income taxes		(29,140	)		(74,239	)
Income tax (provision) benefit		(48	)		706
Net loss	$	(29,188	)	$	(73,533	)
Net loss per common share, basic and diluted	$	(0.09	)	$	(0.24	)
Weighted-average common shares outstanding, basic and diluted		309,141			306,363

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

4

The Beachbody Company, Inc.

Unaudited Condensed Consolidated Statements of Comprehensive Loss

(in thousands)

	Three months ended March 31,
	2023			2022
Net loss	$	(29,188	)	$	(73,533	)
Other comprehensive income (loss):
Change in fair value of derivative financial instruments, net of tax		(147	)		(185	)
Reclassification of (losses) gains on derivative financial instruments   included in net loss		(87	)		69
Foreign currency translation adjustment		10			4
Total other comprehensive loss		(224	)		(112	)
Total comprehensive loss	$	(29,412	)	$	(73,645	)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

5

The Beachbody Company, Inc.

Unaudited Condensed Consolidated Statements of Stockholders’ Equity

(in thousands)

									Retained			Accumulated
						Additional			Earnings			Other			Total
	Common Stock					Paid-In			(Accumulated)			Comprehensive			Stockholders’
	Shares			Amount		Capital			(Deficit)			Income (Loss)			Equity
Balances at December 31, 2021		309,584		$	31	$	610,418		$	(225,043	)	$	(21	)	$	385,385
Net loss		—			—		—			(73,533	)		—			(73,533	)
Other comprehensive loss		—			—		—			—			(112	)		(112	)
Equity-based compensation		—			—		4,564			—			—			4,564
Options exercised, net of tax withholdings		1,132			—		1,923			—			—			1,923
Balances at March 31, 2022		310,716		$	31	$	616,905		$	(298,576	)	$	(133	)	$	318,227
												Accumulated
						Additional						Other			Total
	Common Stock					Paid-In			Accumulated			Comprehensive			Stockholders’
	Shares			Amount		Capital			Deficit			Income (Loss)			Equity
Balances at December 31, 2022		312,162		$	31	$	630,709		$	(419,235	)	$	37		$	211,542
Net loss		—			—		—			(29,188	)		—			(29,188	)
Other comprehensive loss		—			—		—			—			(224	)		(224	)
Equity-based compensation		9,736			1		9,554			—			—			9,555
Shares withheld for tax withholdings on vesting of restricted stock		(3,644	)		—		(2,128	)		—			—			(2,128	)
Balances at March 31, 2023		318,254		$	32	$	638,135		$	(448,423	)	$	(187	)	$	189,557

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

6

The Beachbody Company, Inc.

Unaudited Condensed Consolidated Statements of Cash Flows

(in thousands)

	Three months ended March 31,
	2023			2022
Cash flows from operating activities:
Net loss	$	(29,188	)	$	(73,533	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense		10,713			21,587
Amortization of content assets		5,561			6,164
Provision for inventory and inventory purchase commitments		2,734			16,896
Realized (gains) losses on hedging derivative financial instruments		(87	)		69
Change in fair value of warrant liabilities		(57	)		(264	)
Equity-based compensation		9,555			4,564
Deferred income taxes		(53	)		(808	)
Amortization of debt issuance costs		479			—
Paid-in-kind interest expense		374			—
Other non-cash items		—			91
Changes in operating assets and liabilities:
Inventory		3,056			15,887
Content assets		(2,224	)		(6,448	)
Prepaid expenses		1,652			(293	)
Other assets		(4,958	)		2,895
Accounts payable		(1,366	)		(20,752	)
Accrued expenses		(8,768	)		(1,386	)
Deferred revenue		4,746			2,370
Other liabilities		(38	)		(410	)
Net cash used in operating activities		(7,869	)		(33,371	)
Cash flows from investing activities:
Purchase of property and equipment		(3,417	)		(12,403	)
Net cash used in investing activities		(3,417	)		(12,403	)
Cash flows from financing activities:
Proceeds from exercise of stock options		—			2,115
Remittance of taxes withheld from employee stock awards		—			(192	)
Debt repayments		(313	)		—
Tax withholding payments for vesting of restricted stock		(2,128	)		—
Net cash (used in) provided by financing activities		(2,441	)		1,923
Effect of exchange rates on cash		29			223
Net decrease in cash and cash equivalents		(13,698	)		(43,628	)
Cash, cash equivalents and restricted cash, beginning of period		80,091			107,054
Cash and cash equivalents, end of period	$	66,393		$	63,426
Supplemental disclosure of cash flow information:
Cash paid during the period for interest	$	1,464		$	10
Cash (received) paid during the year for income taxes, net		(265	)		32
Supplemental disclosure of noncash investing activities:
Property and equipment acquired but not yet paid for	$	1,291		$	4,225

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

7

The Beachbody Company, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

1. Description of Business and Summary of Significant Accounting Policies

Business

The Beachbody Company, Inc. (“Beachbody” or the “Company”) is a leading subscription health and wellness company and the creator of some of the world’s most popular fitness programs. The Company’s fitness programs are available for streaming through subscription to Beachbody On Demand (“BOD”) and, together with the Company’s live fitness and comprehensive nutrition programs, through subscription to Beachbody On Demand Interactive (“BODi”). During the three months ended March 31, 2023, the Company launched an improved BODi experience and began migrating all BOD-only members to BODi on their renewal dates. Beachbody offers nutritional products such as Shakeology nutrition shakes, BEACHBAR snack bars, and Ladder premium supplements, which have been designed and clinically tested to help customers achieve their goals. Beachbody also offers a professional-grade stationary cycle with a 360-degree touch screen tablet and connected fitness software. The Company’s revenue has historically been generated primarily through a network of micro-influencers (“Partners”) (previously known as “Coaches”), social media marketing channels, and direct response advertising. References to “Coaches” throughout this report have been updated to “Partners.”

Basis of Presentation and Principles of Consolidation

The Company prepares its consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information as determined by the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) and pursuant to the regulations of the U.S. Securities and Exchange Commission (“SEC”).

The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that impact the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Significant estimates include, but are not limited to, the useful life and recoverability of long-lived assets, the valuation of warrant liabilities, the recognition and measurement of income tax assets and liabilities, the valuation of intangible assets, impairment of goodwill, and the net realizable value of inventory. The Company bases these estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgements about the carrying amounts of assets and liabilities. Actual results could differ from those estimates.

The unaudited condensed consolidated financial statements have been prepared on the same basis as the annual audited consolidated financial statements and, in the opinion of management, include all normal recurring adjustments necessary for the fair statement of the Company’s financial position, results of operations, and cash flows. The financial data and other financial information disclosed in the notes to these unaudited condensed consolidated financial statements are also unaudited. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the related notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. Interim results are not necessarily indicative of the results expected for the full fiscal year or any other period.

Recently Adopted Accounting Pronouncements

In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which requires an acquirer to apply ASC 606 to recognize and measure contract assets and liabilities from contracts with customers acquired in a business combination on the acquisition date rather than the general guidance in ASC 805. The Company adopted this new accounting guidance on a prospective basis on January 1, 2023, and the adoption did not have a material effect on its unaudited condensed consolidated financial statements.

In September 2022, the FASB issued ASU 2022-04, Liabilities-Supplier Finance Programs (Topic 405-50) - Disclosure of Supplier Finance Program Obligations, which requires that a buyer in a supplier finance program disclose sufficient information about the program to allow a user of financial statements to understand the program’s nature, activity during the period, changes from period to period, and potential magnitude. The Company adopted this new accounting guidance on a prospective basis on January 1, 2023, and the adoption did not have a material effect on its unaudited condensed consolidated financial statements.

8

2. Revenue

The Company’s revenue disaggregated by geographic region is as follows (in thousands):

	Three months ended March 31,
	2023		2022
Geographic region:
United States	$	130,877	$	178,607
Rest of world1		14,024		20,315
Total revenue	$	144,901	$	198,922

(1) Consists of Canada, United Kingdom, and France. No single country accounted for more than 10% of total revenue during the three months ended March 31, 2023 and 2022.

The Company determined that, in addition to the preceding table, the disaggregation of revenue by revenue type as presented in the unaudited condensed consolidated statements of operations achieves the disclosure requirement to disaggregate revenue into categories that depict how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors.

Deferred Revenue

Deferred revenue is recorded for nonrefundable cash payments received for the Company’s performance obligation to transfer, or stand ready to transfer, goods or services in the future. Deferred revenue consists of subscription fees billed that have not been recognized and physical products sold that have not yet been delivered. During the three months ended March 31, 2023, the Company recognized $53.1 million of revenue that was included in the deferred revenue balance as of December 31, 2022. During the three months ended March 31, 2022, the Company recognized $62.5 million of revenue that was included in the deferred revenue balance as of December 31, 2021.

3. Fair Value Measurements

The Company’s financial assets and liabilities subject to fair value measurements on a recurring basis and the level of inputs used for such measurements were as follows (in thousands):

	March 31, 2023
	Level 1		Level 2		Level 3
Assets
Derivative assets	$	—	$	249	$	—
Total assets	$	—	$	249	$	—
Liabilities
Public warrants	$	600	$	—	$	—
Private placement warrants		—		—		53
Term Loan warrants		—		—		1,038
Total liabilities	$	600	$	—	$	1,091
	December 31, 2022
	Level 1		Level 2		Level 3
Assets
Derivative assets	$	—	$	462	$	—
Total assets	$	—	$	462	$	—
Liabilities
Public Warrants	$	415	$	—	$	—
Private Placement Warrants		—		—		107
Term Loan Warrants		—		—		1,226
Total liabilities	$	415	$	—	$	1,333

9

Fair values of cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses approximate the recorded value due to the short period of time to maturity. The fair value of the public warrants, which trade in active markets, is based on quoted market prices. The fair value of derivative instruments is based on Level 2 inputs such as observable forward rates, spot rates, and foreign currency exchange rates. The Company’s private placement and Term Loan warrants are classified within Level 3 of the fair value hierarchy because their fair values are based on significant inputs that are unobservable in the market.

Private Placement Warrants

The Company determined the fair value of the private placement warrants using a Black-Scholes option-pricing model and the quoted price of the Company’s Class A Common Stock. Volatility was based on the implied volatility derived primarily from the average of the actual market activity of the Company’s peer group. The expected life was based on the remaining contractual term of the private placement warrants, and the risk-free interest rate was based on the implied yield available on U.S. treasury securities with a maturity equivalent to the warrants’ expected life. The significant unobservable input used in the fair value measurement of the private placement warrants is the implied volatility. Significant changes in the implied volatility would result in a significantly higher or lower fair value measurement, respectively.

The following table presents significant assumptions utilized in the valuation of the private placement warrants on March 31, 2023 and December 31, 2022:

	March 31, 2023			December 31, 2022
Risk-free rate		3.8	%		4.2	%
Dividend yield rate		—			—
Volatility		75.0	%		75.0	%
Contractual term (in years)		3.24			3.49
Exercise price	$	11.50		$	11.50

The following table presents changes in the fair value of the private placement warrants for the three months ended March 31, 2023 and 2022 (in thousands):

	Three months ended March 31,
	2023			2022
Balance, beginning of period	$	107		$	2,133
Change in fair value		(54	)		(213	)
Balance, end of period	$	53		$	1,920

For the three months ended March 31, 2023 and 2022, the change in the fair value of private placement warrants resulted from the change in price of the Company’s Class A Common Stock, remaining contractual term, and risk-free rate. The changes in fair value are included in the unaudited condensed consolidated statements of operations as a component of change in fair value of warrant liabilities and in the unaudited condensed consolidated balance sheets as other liabilities.

Term Loan Warrants

The Company determined the fair value of the Term Loan warrants using a Black-Scholes option-pricing model and the quoted price of the Company’s Class A Common Stock. Volatility was based on the implied volatility derived primarily from the average of the actual market activity of the Company’s peer group. The expected life was based on the remaining contractual term of the Term Loan warrants, and the risk-free interest rate was based on the implied yield available on U.S. treasury securities with a maturity equivalent to the warrants’ expected life. The significant unobservable input used in the fair value measurement of the Term Loan warrants is the implied volatility. Significant changes in the implied volatility would result in a significantly higher or lower fair value measurement, respectively. See Note 9, Debt, for additional information regarding the Term Loan warrants.

10

The following table presents significant assumptions utilized in the valuation of the Term Loan Warrants at March 31, 2023 and December 31, 2022:

	March 31, 2023			December 31, 2022
Risk-free rate		3.6	%		4.0	%
Dividend yield rate		—			—
Volatility		75.0	%		75.0	%
Contractual term (in years)		6.36			6.61
Exercise price	$	1.85		$	1.85

The following table presents changes in the fair value of the Term Loan warrants for the three months ended March 31, 2023 and 2022 (in thousands):

	Three months ended March 31,
	2023			2022
Balance, beginning of period	$	1,226		$	—
Change in fair value		(188	)		—
Balance, end of period	$	1,038		$	—

4. Inventory, Net

Inventory, net consists of the following (in thousands):

	March 31, 2023		December 31, 2022
Raw materials and work in process	$	12,620	$	13,380
Finished goods		35,684		40,680
Total inventory, net	$	48,304	$	54,060

Adjustments to the carrying value of excess inventory and inventory on hand to net realizable value were $2.7 million and $16.9 million during the three months ended March 31, 2023 and 2022, respectively. These adjustments are included in the unaudited condensed consolidated statements of operations as a component of nutrition and other cost of revenue and connected fitness cost of revenue. The Company recorded $1.3 million and $2.5 million in nutrition and other cost of revenue for the three months ended March 31, 2023 and 2022, respectively, and $1.4 million and $14.4 million in connected fitness cost of revenue for the three months ended March 31, 2023 and 2022, respectively.

5. Other Current Assets

Other current assets consist of the following (in thousands):

	March 31, 2023		December 31, 2022
Deferred partner costs	$	35,301	$	31,270
Deposits		5,876		4,527
Accounts receivable, net		1,839		866
Other		2,671		2,585
Total other current assets	$	45,687	$	39,248

11

6. Property and Equipment, Net

Property and equipment, net consists of the following (in thousands):

	March 31, 2023			December 31, 2022
Computer software and web development	$	224,851		$	236,533
Computer equipment		23,452			24,240
Buildings		5,158			5,158
Leasehold improvements		4,600			4,600
Furniture, fixtures and equipment		1,207			1,222
Computer software and web development projects in-process		7,028			5,147
Property and equipment, gross		266,296			276,900
Less: Accumulated depreciation		(198,901	)		(202,753	)
Total property and equipment, net	$	67,395		$	74,147

The Company recorded depreciation expense related to property and equipment in the following expense categories of its unaudited condensed consolidated statements of operations as follows (in thousands):

	Three months ended March 31,
	2023		2022
Cost of revenue	$	4,932	$	9,081
Selling and marketing		—		279
Enterprise technology and development		4,503		7,449
General and administrative		1		192
Total depreciation	$	9,436	$	17,001

7. Accrued Expenses

Accrued expenses consist of the followings (in thousands):

	March 31, 2023		December 31, 2022
Inventory, shipping and fulfillment	$	13,233	$	11,687
Partner costs		13,047		14,535
Employee compensation and benefits		10,610		20,584
Sales and other taxes		4,891		4,818
Information technology		2,545		2,207
Advertising		1,773		1,176
Customer service expenses		790		956
Other accrued expenses		7,895		8,467
Total accrued expenses	$	54,784	$	64,430

Advertising costs, which are primarily comprised of social media, television media, and internet advertising expenses and also include print, radio, and infomercial production costs, were $9.0 million and $15.8 million for the three months ended March 31, 2023 and 2022, respectively.

12

8. Commitments and Contingencies

Inventory Purchase and Service Agreements

The Company has noncancelable inventory purchase and service agreements with multiple service providers which expire at varying dates through 2028. Service agreement obligations include amounts related to fitness and nutrition trainers, future events, information systems support, and other technology projects.

Future minimum payments under noncancelable service and inventory purchase agreements for the periods succeeding March 31, 2023 are as follows (in thousands):

Nine months ending December 31, 2023	$	26,651
Year ending December 31, 2024		2,039
Year ending December 31, 2025		1,475
Year ending December 31, 2026		100
Year ending December 31, 2027		75
Thereafter		75
	$	30,415

The preceding table excludes royalty payments to fitness trainers, talent, and others that are based on future sales as such amounts cannot be reasonably estimated.

Lease Commitments

The Company leases facilities under noncancelable operating leases expiring through 2027 and certain equipment under a finance lease expiring in 2024. These lease obligations will require payments of approximately $1.8 million during the nine months ending December 31, 2023 and $3.6 million for the year ending December 31, 2024 and thereafter through 2027.

Contingencies

The Company is subject to litigation from time to time in the ordinary course of business. Such claims typically involve its products, intellectual property, and relationships with suppliers, customers, distributors, employees, and others. Contingent liabilities are recorded when it is both probable that a loss has occurred and the amount of the loss can be reasonable estimated. Although it is not possible to predict how litigation and other claims will be resolved, the Company does not believe that any currently identified claims or litigation matters will have a material adverse effect on its consolidated financial position or results of operations.

13

9. Debt

On August 8, 2022 (the “Effective Date”), the Company, Beachbody, LLC as borrower (a wholly owned subsidiary of the Company), and certain other subsidiaries of the Company as guarantors on the signature pages (the “Guarantors”), the lenders (the “Lenders”), and Blue Torch Finance, LLC, as administrative agent and collateral agent for such lenders (the “Term Loan Agent”) entered into a financing agreement (the “Financing Agreement”). The Financing Agreement provides for senior secured term loans on the Effective Date in an aggregate principal amount of $50.0 million (the “Term Loan”) which was drawn on the Effective Date. In addition, the Financing Agreement permits the Company to borrow up to an additional $25.0 million, subject to the terms and conditions set forth in the Financing Agreement. Borrowings under the Term Loan are unconditionally guaranteed by the Guarantors, and all present and future material U.S. and Canadian subsidiaries of the Company. Such security interest consists of a first-priority perfected lien on substantially all property and assets of the Company and subsidiaries, including stock pledges on the capital stock of the Company’s material and direct subsidiaries, subject to customary carveouts. In connection with the Financing Agreement, the Company incurred $4.2 million of third-party debt issuance costs which are recorded in the unaudited condensed consolidated balance sheets as a reduction of long-term debt as of March 31, 2023 and December 31, 2022 and are being amortized over the term of the Term Loan using the effective-interest method. As of March 31, 2023, borrowings outstanding under the Term Loan were $49.1 million. The Term Loan matures on August 8, 2026.

The Term Loan borrowings may take the form of base rate (“Reference Rate”) loans or Secured Overnight Financing Rate (“SOFR”) loans. Reference Rate loans bear interest at a rate per annum equal to the sum of an applicable margin of 6.15% per annum, plus the greater of (a) 2.00% per annum, (b) the Federal Funds Rate plus 0.50% per annum, (c) the “SOFR Rate” (based upon an interest period of 1 month) plus 1.00% per annum, and (d) the rate last quoted by The Wall Street Journal. SOFR loans bear interest at a rate per annum equal to the sum of an applicable margin of 7.15% and the “SOFR Rate” (based upon an interest period of 3 months). The “SOFR Rate” is subject to a floor of 1.00%. In addition, the Term Loan borrowings bear additional interest at 3.00% per annum, paid in kind by capitalizing such interest and adding such capitalized interest to the outstanding principal amount of the loans on each anniversary of the Effective Date. The $50.0 million Term Loan was a SOFR loan, with a cash interest rate of 12.03%. The Company recorded $2.3 million of interest related to the Term Loan during the three months ended March 31, 2023.

The Financing Agreement contains financial covenants that require us to maintain (a) certain minimum revenue levels, to be tested on a quarterly basis, and (b) minimum Liquidity (as defined in the Financing Agreement) of (i) $12.5 million at all times through June 30, 2023, and (ii) $15.0 million at all times thereafter through the maturity of the term loan facility. We were in compliance with these covenants as of March 31, 2023.

In connection with the Term Loan, the Company issued to certain holders affiliated with Blue Torch Finance, LLC warrants for the purchase of 4,716,756 shares of the Company’s Class A Common Stock at an exercise price of $1.85 per share. The warrants vest on a monthly basis over four years, with 30%, 30%, 20% and 20% vesting in the first, second, third and fourth years, respectively. The warrants have a seven-year term from the Effective Date. See Note 3, Fair Value Measurements, for information on the valuation of the warrants. The warrants were recorded in the unaudited condensed consolidated balance sheets as warrant liabilities. The initial fair value of the warrants, of $5.2 million, is being amortized as a debt discount over the term of the Term Loan using the effective-interest method.

The aggregate amounts of payments due for the periods succeeding March 31, 2023 and reconciliation of the Company’s debt balances, net of debt discount and debt issuance costs, are as follows (in thousands):

Nine months ending December 31, 2023	$	937
Year ending December 31, 2024		1,563
Year ending December 31, 2025		2,500
Year ending December 31, 2026		44,063
Total debt	$	49,063
Less current portion		(1,250	)
Less unamortized debt discount and debt issuance costs		(8,509	)
Add capitalized paid-in-kind interest		972
Total long-term debt	$	40,276

The Term Loan amortizes at 2.50% per year from the Effective Date to the date that is the second anniversary of the Effective Date, payable on a quarterly basis, and thereafter, at 5.00% per year, payable on a quarterly basis. The Financing Agreement contains certain customary covenants, including minimum revenue, with which the Company was in compliance as of March 31, 2023.

14

10. Stockholders’ Equity

As of March 31, 2023, 2,000,000,000 shares, $0.0001 par value per share are authorized, of which, 1,600,000,000 shares are designated as Class A Common Stock, 200,000,000 shares are designated as Class X Common Stock, 100,000,000 shares are designated as Class C Common Stock and 100,000,000 shares are designated as Preferred Stock.

Holders of each share of each class of Common Stock are entitled to dividends when, as, and if declared by the Company’s board of directors, subject to the rights and preferences of any holders of Preferred Stock outstanding at the time. The holder of each Class A Common Stock is entitled to one vote, the holder of each share of Class X Common Stock is entitled to ten votes and except as otherwise required by law, the holder of each share of Class C Common Stock is not entitled to any voting powers.

Accumulated Other Comprehensive Income (Loss)

The following tables summarize changes in accumulated other comprehensive income (loss) by component during the three months ended March 31, 2023 and 2022 (in thousands):

	Unrealized Gain (Loss) on Derivatives			Foreign Currency Translation Adjustment			Total
Balances at December 31, 2021	$	(32	)	$	11		$	(21	)
Other comprehensive loss before reclassifications		(162	)		4			(158	)
Amounts reclassified from accumulated other comprehensive income (loss)		69			—			69
Tax effect		(23	)		—			(23	)
Balances at March 31, 2022	$	(148	)	$	15		$	(133	)
Balances at December 31, 2022	$	131		$	(94	)	$	37
Other comprehensive loss before reclassifications		(101	)		10			(91	)
Amounts reclassified from accumulated other comprehensive income (loss)		(87	)		—			(87	)
Tax effect		(46	)		—			(46	)
Balances at March 31, 2023	$	(103	)	$	(84	)	$	(187	)

15

11. Equity-Based Compensation

Equity Compensation Plans

A summary of the option activity under the Company’s equity compensation plans is as follows:

	Options Outstanding
	Number of Options			Weighted-Average Exercise Price (per option)		Weighted-Average Remaining Contractual Term (in years)		Aggregate Intrinsic Value (in thousands)
Outstanding at December 31, 2022		48,414,625		$	2.65		6.35	$	—
Granted		3,463,488			0.63
Forfeited		(3,272,682	)		2.80
Expired		(496,499	)		2.54
Outstanding at March 31, 2023		48,108,932		$	2.49		5.91	$	—
Exercisable at March 31, 2023		23,015,721		$	2.48		2.86	$	—

A summary of RSU activity is as follows:

	RSUs Outstanding
	Number of RSUs			Weighted-Average Fair Value (per RSU)
Outstanding at December 31, 2022		3,159,185		$	1.45
Granted		22,676,189			0.58
Vested		(9,736,133	)		0.60
Forfeited		(619,173	)		0.96
Outstanding at March 31, 2023		15,480,068		$	0.73

The fair value of RSUs vested during the three months ended March 31, 2023 was $5.9 million. No RSUs vested during the three months ended March 31, 2022.

On January 1, 2023, the number of shares available for issuance under the 2021 Incentive Award Plan (the “2021 Plan”) increased by 15,608,106 pursuant to the terms of the 2021 Plan. As of March 31, 2023, 11,663,071 shares of Class A Common Stock were available for issuance under the 2021 Plan.

Vested RSUs included shares of common stock that the Company withheld on behalf of certain employees to satisfy the minimum statutory tax withholding requirements, as defined by the Company. The Company withheld shares of common stock with an aggregate fair value and remitted taxes of $2.1 million during the three months ended March 31, 2023, which were classified as financing cash outflows in the unaudited condensed consolidated statements of cash flows. The Company canceled and returned these shares to the 2021 Plan, which are available under the plan terms for future issuance.

Equity-Based Compensation Expense

The fair value of each award as of the date of grant is estimated using a Black-Scholes option-pricing model. The following table summarizes the weighted-average assumptions used to determine the fair value of option grants:

	Three months ended March 31,
	2023			2022
Risk-free rate		3.6	%		1.7	%
Dividend yield rate		—			—
Volatility		56.4	%		52.3	%
Expected term (in years)		5.16			6.20
Weighted-average grant date fair value	$	0.32		$	0.95

16

Equity-based compensation expense for the three months ended March 31, 2023 and 2022 was as follows (in thousands):

	Three months ended March 31,
	2023		2022
Cost of revenue	$	1,429	$	335
Selling and marketing		3,386		1,639
Enterprise technology and development		563		927
General and administrative		4,177		1,663
Total equity-based compensation	$	9,555	$	4,564

In connection with the restructuring activity that took place during the three months ended March 31, 2023, the Company modified certain stock awards of terminated employees (approximately 102 employees). The modifications included; accelerating the vesting of any options that would have vested within three months of the employees termination date; and all vested options will be available for exercise for a total of six months after the employees’ termination date (that is, three months in addition to the standard three months per original agreement). As a result of these modifications, the Company recognized a $0.6 million reduction to equity-based compensation expense within general and administrative expense in the unaudited condensed consolidated statements of operations.

As of March 31, 2023, the total unrecognized equity-based compensation expense was $38.8 million, which will be recognized over a weighted-average remaining period of 2.88 years.

12. Derivative Financial Instruments

As of March 31, 2023 and December 31, 2022, the notional amount of the Company’s outstanding foreign exchange options was $16.7 million and $17.6 million, respectively. There were no outstanding forward contracts as of March 31, 2023 and December 31, 2022.

The following table shows the pre-tax effects of the Company’s derivative instruments on its unaudited condensed consolidated statements of operations (in thousands):

		Three months ended March 31,
	Financial Statement Line Item	2023			2022
Unrealized gains (losses)	Other comprehensive income (loss)	$	(101	)	$	(162	)
Gains (losses) reclassified from accumulated other	Cost of revenue	$	36		$	(30	)
comprehensive income into net loss	General and administrative		51			(39	)
Total amounts reclassified		$	87		$	(69	)
Gains (losses) recognized on derivatives   not designated as hedging instruments	Cost of revenue	$	(41	)	$	(51	)

17

13. Restructuring

In 2023, restructuring charges primarily relate to activities focused on aligning the Company's operations with its key growth priorities. Restructuring charges in 2022 relate to the consolidation of our streaming fitness and nutrition offerings into a single Beachbody platform. The Company recognized restructuring costs of $5.4 million and $7.2 million during the three months ended March 31, 2023 and 2022, respectively, comprised primarily of termination benefits related to headcount reductions, of which $1.4 million is included in accrued expenses in the unaudited condensed consolidated balance sheets. In accordance with GAAP, employee termination benefits were recognized at the date employees were notified and post-employment benefits were accrued as the obligation was probable and estimable. Benefits for employees who provided service greater than 60 days from the date of notification were recognized ratably over the service period.

The following table summarizes activity in the Company’s restructuring-related liability during the three months ended March 31, 2023 (in thousands):

	Balance at		Restructuring		Payments /			Liability at
	December 31, 2022		Charges		Utilizations			March 31, 2023
Employee-related costs	$	469	$	5,387	$	(4,467	)	$	1,389
Total costs	$	469	$	5,387	$	(4,467	)	$	1,389

The Company expects to incur additional charges of approximately $0.2 million related to termination benefits as it fully implements its strategic alignment initiative.

14. Income Taxes

The Company recorded a provision for income taxes of approximately zero for the three months ended March 31, 2023, and a benefit for income taxes of $0.7 million for the three months ended March 31, 2022. The effective tax rate was (0.2)% for the three months ended March 31, 2023, and the effective benefit tax rate was 1.0% for the three months ended March 31, 2022.

The tax provision for interim periods is determined using an estimate of the Company’s annual effective tax rate, adjusted for discrete items arising in that quarter. The Company’s effective tax rate differs from the U.S. statutory tax rate in the three months ended March 31, 2023 primarily due to changes in valuation allowances on deferred tax assets as it is more likely than not that some or all of the Company’s deferred tax assets will not be realized.

The Company evaluates its tax positions on a quarterly basis and revises its estimate accordingly. There were no material changes to the Company’s uncertain tax positions, interest, or penalties during the three months ended March 31, 2023.

18

15. Earnings (Loss) per Share

The computation of loss per share of Class A and Class X Common Stock is as follows (in thousands, except share and per share information):

	Three months ended March 31,
	2023			2022
Numerator:
Net loss	$	(29,188	)	$	(73,533	)
Denominator:
Weighted-average common shares outstanding, basic and diluted		309,140,558			306,362,730
Net loss per common share, basic and diluted	$	(0.09	)	$	(0.24	)

Basic net loss per common share is the same as dilutive net loss per common share for each of the three months ended March 31, 2023 and 2022 as the inclusion of all potential common shares would have been antidilutive.

The following table presents the common shares that are excluded from the computation of diluted net loss per common share as of the periods presented because including them would have been antidilutive:

	March 31,
	2023		2022
Options		48,108,932		38,674,077
RSUs		15,480,068		322,596
Compensation warrants		3,980,656		3,980,656
Public and private placement warrants		15,333,333		15,333,333
Term Loan warrants		4,716,756		—
Earn-out shares		3,750,000		3,750,000
		91,369,745		62,060,662

19

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion and analysis should be read in conjunction with our financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q (this “Report”) and the section entitled “Risk Factors.” Unless otherwise indicated, the terms “Beachbody,” “we,” “us,” or “our” refer to The Beachbody Company, Inc., a Delaware corporation, together with its consolidated subsidiaries.

Forward-Looking Statements

This Report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (“Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (“Exchange Act”), including statements about and the financial condition, results of operations, earnings outlook and prospects of the Company. Forward-looking statements are typically identified by words such as “plan,” “believe,” “expect,” “anticipate,” “intend,” “outlook,” “estimate,” “forecast,” “project,” “continue,” “could,” “may,” “might,” “possible,” “potential,” “predict,” “should,” “would” and other similar words and expressions, but the absence of these words does not mean that a statement is not forward-looking.

The forward-looking statements are based on our current expectations as applicable and are inherently subject to uncertainties and changes in circumstances and their potential effects and speak only as of the date of such statement. There can be no assurance that future developments will be those that have been anticipated. These forward-looking statements involve a number of risks, uncertainties or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to the following:

•our future financial performance, including our expectations regarding our revenue, cost of revenue, gross profit, operating expenses including changes in selling and marketing, general and administrative, and enterprise technology and development expenses (including any components of the foregoing), Adjusted EBITDA (as defined below) and our ability to achieve and maintain future profitability;

•our anticipated growth rate and market opportunity;

•our liquidity and ability to raise financing;

•our success in retaining or recruiting, or changes required in, officers, key employees or directors;

•our warrants are accounted for as liabilities and changes in the value of such warrants could have a material effect on our financial results;

•our ability to effectively compete in the fitness and nutrition industries;

•our ability to successfully acquire and integrate new operations;

•our reliance on a few key products;

•market conditions and global and economic factors beyond our control;

•intense competition and competitive pressures from other companies worldwide in the industries in which we will operate;

•litigation and the ability to adequately protect our intellectual property rights; and

•other risk and uncertainties set forth in this Report under the heading “Risk Factors.”

Should one or more of these risks or uncertainties materialize or should any of the assumptions made by management prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements.

Except to the extent required by applicable law or regulation, we undertake no obligation to update these forward-looking statements to reflect events or circumstances after the date of this Report or to reflect the occurrence of unanticipated events.

20

Overview

Beachbody is a leading subscription health and wellness company. We focus primarily on digital content, supplements, connected fitness, and consumer health and wellness. Our goal is to continue to provide holistic health and wellness content and subscription-based solutions. We are the creator of some of the world’s most popular fitness programs, including P90X, Insanity, and 21 Day Fix, which transformed the at-home fitness market and disrupted the global fitness industry by making it accessible for people to get results—anytime, anywhere. Our comprehensive nutrition-first programs, Portion Fix and 2B Mindset, teach healthy eating habits and promote healthy, sustainable weight loss. These fitness and nutrition programs are available through our Beachbody On Demand and Beachbody On Demand Interactive streaming services.

We offer nutritional products such as Shakeology nutrition shakes, BEACHBAR snack bars, and Ladder premium supplements as well as a professional-grade stationary cycle with a 360-degree touch screen tablet and connected fitness software. Leveraging our history of fitness content creation, nutrition innovation, and our network of micro-influencers, whom we call “Partners” (previously known as “Coaches”), we plan to continue market penetration into connected fitness to reach a wider health, wellness and fitness audience.

Our revenue is generated primarily through our network of Partners, social media marketing channels, and direct response advertising. Components of revenue include recurring digital subscription revenue, revenue from the sale of nutritional and other products, and connected fitness revenue. In addition to selling individual products on a one-time basis, we bundle digital and nutritional products together at discounted prices.

For the three months ended March 31, 2023, as compared to the three months ended March 31, 2022:

•Total revenue was $144.9 million, a 27% decrease;

•Digital revenue was $64.8 million, a 21% decrease;

•Nutrition and other revenue was $74.1 million, a 24% decrease;

•Connected fitness revenue was $6.0 million, a 69% decrease;

•Net loss was $29.2 million, compared to net loss of $73.5 million; and

•Adjusted EBITDA was ($0.9) million, compared to ($19.1) million.

See “Non-GAAP Information” below for information regarding our use of Adjusted EBITDA and a reconciliation of net loss to Adjusted EBITDA.

Recent Developments

Our key growth priorities for 2023 include: revamping our Beachbody on Demand (“BODi”) digital platform, growing Shakeology in the Healthy Dessert market, and improving the affordability of our connected fitness bike. In March 2023, we relaunched the BODi digital platform with a new form of fitness programming called BODi Blocks, the addition of positive mindset content, and digital recipes to extend Shakeology into a Healthy Dessert. We also began migrating all BOD-only members to BODi on their renewal dates. During the first quarter of 2023, to align our operations with our key growth priorities, we executed certain restructuring activities, including a reduction in headcount. These actions are expected to result in aggregate charges of $5.6 million, consisting primarily of termination benefits, of which $5.4 million was incurred during the three months ended March 31, 2023.

21

Key Operational and Business Metrics

We use the following key operational and business metrics to evaluate our business, measure our performance, develop financial forecasts, and make strategic decisions.

	As of March 31,
	2023		2022
Digital subscriptions (millions)		1.75		2.46
Nutritional subscriptions (millions)		0.21		0.30

	Three months ended March 31,
	2023			2022
Average digital retention		95.9	%		95.6	%
Total streams (millions)		29.7			38.2
DAU/MAU		32.5	%		31.6	%
Revenue (millions)	$	144.9		$	198.9
Gross profit (millions)	$	91.3		$	93.0
Gross margin		63	%		47	%
Net loss (millions)	$	(29.2	)	$	(73.5	)
Adjusted EBITDA (millions)	$	(0.9	)	$	(19.1	)

Please see “Non-GAAP Information” below for a reconciliation of net loss to Adjusted EBITDA and an explanation for why we consider Adjusted EBITDA to be a helpful metric for investors.

Digital Subscriptions

Our ability to expand the number of digital subscriptions is an indicator of our market penetration and growth. Digital subscriptions include BOD, BODi, and prior to Q3 2022, Openfit subscriptions. Digital subscriptions include paid and free-to-pay subscriptions, with free-to-pay subscriptions representing approximately 1% of total digital subscriptions on average. Digital subscriptions are inclusive of all billing plans, currently for annual, semi-annual, quarterly and monthly billing intervals.

Nutritional Subscriptions

Nutritional subscriptions include monthly subscriptions for nutritional products such as Shakeology, Beachbody Performance, BEACHBAR, Bevvy and Ladder Supplements. We also package and bundle the content experience of digital subscriptions with nutritional subscriptions to optimize customer results.

Average Digital Retention

We use month-over-month digital subscription retention, which we define as the average rate at which a subscription renews for a new billing cycle, to measure customer retention.

Total Streams

We use total streams to quantify the number of fitness or nutrition programs viewed per subscription, which is a leading indicator of customer engagement and retention. While the measure of a digital stream may vary across companies, to qualify as a stream on any of our digital platforms, a program must be viewed for a minimum of 25% of the total running time.

Daily Active Users to Monthly Active Users (DAU/MAU)

We use the ratio of daily active users to monthly active users to measure how frequently digital subscribers are utilizing our service in a given month. We define a daily active user as a unique user streaming content on our platform in a given day. We define a monthly active user as a unique user streaming content on our platform in that same month.

22

Non-GAAP Information

We use Adjusted EBITDA, which is a non-GAAP performance measure, to supplement our results presented in accordance with GAAP. We believe Adjusted EBITDA is useful in evaluating our operating performance, as it is similar to measures reported by our public competitors and is regularly used by security analysts, institutional investors, and other interested parties in analyzing operating performance and prospects. Adjusted EBITDA is not intended to be a substitute for any GAAP financial measure and, as calculated, may not be comparable to other similarly titled measures of performance of other companies in other industries or within the same industry.

We define and calculate Adjusted EBITDA as net income (loss) adjusted for depreciation and amortization, amortization of capitalized cloud computing implementation costs, amortization of content assets, interest expense, income tax provision (benefit), equity-based compensation, and other items that are not normal, recurring, operating expenses necessary to operate the Company’s business as described in the reconciliation below.

We include this non-GAAP financial measure because it is used by management to evaluate Beachbody’s core operating performance and trends and to make strategic decisions regarding the allocation of capital and new investments. Adjusted EBITDA excludes certain expenses that are required in accordance with GAAP because they are non-cash (for example, in the case of depreciation and amortization, equity-based compensation, and net realizable value adjustment) or are not related to our underlying business performance (for example, in the case of interest income and expense).

The table below presents our Adjusted EBITDA reconciled to our net loss, the closest GAAP measure, for the periods indicated:

	Three months ended March 31,
(in thousands)	2023			2022
Net loss	$	(29,188	)	$	(73,533	)
Adjusted for:
Depreciation and amortization		10,713			21,587
Amortization of capitalized cloud computing implementation costs		41			168
Amortization of content assets		5,561			6,164
Interest expense		2,331			19
Income tax provision (benefit)		48			(706	)
Equity-based compensation		9,555			4,564
Employee incentives, expected to be settled in equity (1)		(5,466	)		—
Inventory net realizable value adjustment (2)		—			14,934
Restructuring and platform consolidation costs (3)		6,059			7,887
Change in fair value of warrant liabilities		(57	)		(264	)
Non-operating (4)		(484	)		72
Adjusted EBITDA	$	(887	)	$	(19,108	)

(1)The non-cash charge for employee incentives which were expected to be settled in equity was recorded and included in the Adjusted EBITDA calculation during the year ended December 31, 2022. During the three months ended March 31, 2023, we reclassified the non-cash charge from employee incentives expected to be settled in equity to equity-based compensation because we settled certain employee incentives with RSU awards during the period.

(2)Represents a non-cash expense to reduce the carrying value of our connected fitness inventory and related future commitments. This adjustment was included during the three months ended March 31, 2022 because of its unusual magnitude due to disruptions in the connected fitness market.

(3)Includes restructuring expense and non-recurring personnel costs associated with executing our key growth priorities during the three months ended March 31, 2023 and with the consolidation of our digital platforms during the three months ended March 31, 2022.

(4)Primarily includes interest income.

23

Results of Operations

The Company has one operating segment. The following discussion of our results and operations is on a consolidated basis.

(in thousands)	Three months ended March 31,
	2023			2022
Revenue:
Digital	$	64,773		$	81,745
Nutrition and other		74,120			97,664
Connected fitness		6,008			19,513
Total revenue		144,901			198,922
Cost of revenue:
Digital		14,967			16,425
Nutrition and other		31,039			44,774
Connected fitness		7,555			44,706
Total cost of revenue		53,561			105,905
Gross profit		91,340			93,017
Operating expenses:
Selling and marketing		76,576			106,444
Enterprise technology and development		19,096			33,697
General and administrative		17,716			20,073
Restructuring		5,387			7,223
Total operating expenses		118,775			167,437
Operating loss		(27,435	)		(74,420	)
Other income (expense)
Change in fair value of warrant liabilities		57			264
Interest expense		(2,331	)		(19	)
Other income, net		569			(64	)
Loss before income taxes		(29,140	)		(74,239	)
Income tax (provision) benefit		(48	)		706
Net loss	$	(29,188	)	$	(73,533	)

24

Revenue

Revenue includes digital subscriptions, nutritional supplement subscriptions, one-time nutritional sales, connected fitness products, access to our online Partner business management platform, preferred customer program memberships, and other fitness-related products. We often sell bundled products that combine digital subscriptions, nutritional products, and/or other fitness products. We consider these sales to be revenue arrangements with multiple performance obligations and allocate the transaction price to each performance obligation based on its relative stand-alone selling price. We defer revenue when we receive payments in advance of delivery of products or the performance of services. Digital subscription revenue is recognized ratably over the subscription period of up to 38 months.

	Three months ended March 31,
	2023		2022		$ Change			% Change
	(dollars in thousands)
Revenue
Digital	$	64,773	$	81,745	$	(16,972	)		(21	%)
Nutrition and other		74,120		97,664		(23,544	)		(24	%)
Connected fitness		6,008		19,513		(13,505	)		(69	%)
Total revenue	$	144,901	$	198,922	$	(54,021	)		(27	%)

The decrease in digital revenue for the three months ended March 31, 2023, as compared to the three months ended March 31, 2022, was primarily due to a decrease in revenue from our digital streaming services due to 29% fewer subscriptions, partially offset by an increase in revenue per subscription.

The decrease in nutrition and other revenue for the three months ended March 31, 2023, as compared to the three months ended March 31, 2022, was primarily due to a $20.4 million decrease in revenue from nutritional products due to 30% fewer nutritional subscriptions and a $1.4 million decrease in fitness accessories revenue.

The decrease in connected fitness revenue for the three months ended March 31, 2023, as compared to the three months ended March 31, 2022, was primarily due to lower demand resulting from reduced promotional activity.

Cost of Revenue

Digital Cost of Revenue

Digital cost of revenue includes costs associated with digital content creation including amortization and revision of content assets, depreciation of streaming platforms, digital streaming costs, and amortization of acquired digital platform intangible assets. It also includes customer service costs, payment processing fees, depreciation of production equipment, live trainer costs, facilities, and related personnel expenses.

Nutrition and Other Cost of Revenue

Nutrition and other cost of revenue includes product costs, shipping and handling, fulfillment and warehousing, customer service, and payment processing fees. It also includes depreciation of nutrition-related e-commerce websites and social commerce platforms, amortization of acquired formulae intangible assets, facilities, and related personnel expenses.

Connected Fitness Cost of Revenue

Connected fitness cost of revenue consists of product costs, including bike and tablet hardware costs, duties and other applicable importing costs, shipping and handling costs, warehousing and logistics costs, costs associated with service calls and repairs of products under warranty, payment processing and financing fees, customer service expenses, and personnel-related expenses associated with supply chain and logistics.

25

	Three months ended March 31,
	2023			2022			$ Change			% Change
	(dollars in thousands)
Cost of revenue
Digital	$	14,967		$	16,425		$	(1,458	)		(9	%)
Nutrition and other		31,039			44,774			(13,735	)		(31	%)
Connected fitness		7,555			44,706			(37,151	)		(83	%)
Total cost of revenue	$	53,561		$	105,905		$	(52,344	)		(49	%)
Gross profit
Digital	$	49,806		$	65,320		$	(15,514	)		(24	%)
Nutrition and other		43,081			52,890			(9,809	)		(19	%)
Connected fitness		(1,547	)		(25,193	)		23,646			94	%
Total gross profit	$	91,340		$	93,017		$	(1,677	)		(2	%)
Gross margin
Digital		77	%		80	%
Nutrition and other		58	%		54	%
Connected fitness		(26	%)		(129	%)

The decrease in digital cost of revenue for the three months ended March 31, 2023, as compared to the three months ended March 31, 2022, was due to a $0.6 million decrease in the amortization of content assets as a result of lower production spend and a $0.4 million decrease in both streaming costs and payment processing fees as a result of lower revenue. The decrease in digital gross margin for the three months ended March 31, 2023 compared to the three months ended March 31, 2022 was primarily the result of fixed expenses on lower digital revenue.

The decrease in nutrition and other cost of revenue for the three months ended March 31, 2023, as compared to the three months ended March 31, 2022, was primarily due to a $5.5 million decrease in product costs and a $3.8 million decrease in fulfillment and shipping expense related to the decrease in nutrition and other revenue, a $1.9 million decrease in depreciation expense as a result of the end of the useful life of certain fixed assets, and a $1.3 million decrease in customer service expense due to a decrease in the volume of contacts related to nutrition and other revenue. Nutrition and other gross margin increased primarily as a result of the favorable shift in revenue to higher-margin products, lower shipping and customer service expense, and lower fixed depreciation expense.

The decrease in connected fitness cost of revenue was driven by lower inventory value adjustments of $14.1 million and an $14.4 million decrease in product costs and a $6.4 million decrease in freight, fulfillment, and shipping expenses as the result of lower connected fitness revenue. The connected fitness negative gross margin improvement for the three months ended March 31, 2023 compared to the three months ended March 31, 2022 was primarily due to lower inventory value adjustments and an increase in average order value, partially offset by the impact of fixed warehousing expenses on lower connected fitness revenue.

Operating Expenses

Selling and Marketing

Selling and marketing expenses primarily include the cost of Partner compensation, advertising, royalties, promotions and events, and third-party sales commissions as well as the personnel expenses for employees and consultants who support these areas. Selling and marketing expense as a percentage of total revenue may fluctuate from period to period based on total revenue, timing of new content and nutritional product launches, and the timing of our media investments to build awareness around launch activity.

	Three months ended March 31,
	2023			2022			$ Change			% Change
	(dollars in thousands)
Selling and marketing	$	76,576		$	106,444		$	(29,868	)		(28	%)
As a percentage of total revenue		52.8	%		53.5	%

The decrease in selling and marketing expense for the three months ended March 31, 2023, as compared to the three months ended March 31, 2022, was primarily due to a $13.9 million decrease in Partner compensation as a result of lower commissionable revenue,

26

$6.1 million decrease in personnel-related expenses due to lower headcount, $6.0 million decrease in online and television media expense related to our media investment strategy which was implemented in Q1 2022, and a $2.5 million decrease in the amortization of intangible assets due to the impairment of certain assets in Q4 2022.

Selling and marketing expense as a percentage of total revenue decreased by 70 basis points primarily due to lower fixed expenses, partially offset by the shift in revenue mix to higher-commission products.

Enterprise Technology and Development

Enterprise technology and development expenses primarily relate to enterprise systems applications, hardware, and software that serve as the technology infrastructure for the Company and are not directly related to services provided or tangible goods sold. This includes maintenance and enhancements of the Company’s enterprise resource planning system, which is the core of our accounting, procurement, supply chain and other business support systems. Enterprise technology and development also includes reporting and business analytics tools, security systems such as identity management and payment card industry compliance, office productivity software, research and development tracking tools, and other non-customer facing applications. Enterprise technology and development expenses include personnel-related expenses for employees and consultants who create improvements to and maintain technology systems and are involved in the research and development of new and existing nutritional products, depreciation of enterprise technology-related assets, software licenses, hosting expenses, and technology equipment leases.

	Three months ended March 31,
	2023			2022			$ Change			% Change
	(dollars in thousands)
Enterprise technology and development	$	19,096		$	33,697		$	(14,601	)		(43	%)
As a percentage of total revenue		13.2	%		16.9	%

The decrease in enterprise technology and development expense for the three months ended March 31, 2023, as compared to the three months ended March 31, 2022, was primarily due to an $11.7 million decrease in personnel-related expenses due to lower headcount and a $2.9 million decrease in depreciation expense as a result of the end of the useful life of certain fixed assets.

Enterprise technology and development expense as a percentage of total revenue decreased by 370 basis points due to lower fixed expenses.

General and Administrative

General and administrative expense includes personnel-related expenses and facilities-related costs primarily for our executive, finance, accounting, legal and human resources functions. General and administrative expense also includes fees for professional services principally comprised of legal, audit, tax, and insurance.

	Three months ended March 31,
	2023			2022			$ Change			% Change
	(dollars in thousands)
General and administrative	$	17,716		$	20,073		$	(2,357	)		(12	%)
As a percentage of total revenue		12.2	%		10.1	%

27

The decrease in general and administrative expense for the three months ended March 31, 2023, as compared to the three months ended March 31, 2022, was primarily due to $2.2 million decrease in personnel-related expenses as a result of lower headcount.

General and administrative expense as a percentage of total revenue increased by 210 basis points due to lower total revenue.

Restructuring

In 2023, restructuring charges primarily relate to activities focused on aligning our operations with our key growth priorities, including a reduction in headcount. Restructuring charges in 2022 relate to the consolidation of our streaming fitness and nutrition offerings into a single Beachbody platform. The charges incurred primarily consist of employee termination costs.

	Three months ended March 31,
	2023		2022		$ Change			% Change
	(dollars in thousands)
Restructuring	$	5,387	$	7,223	$	(1,836	)		(25	%)

Other Income (Expense)

The change in fair value of warrant liabilities consists of the fair value changes of the public, private placement, and Term Loan warrants. Interest expense primarily consists of interest expense associated with our borrowings and amortization of debt discount and issuance costs for our Term Loan in 2022 and Credit Facility in 2021. Other income, net, consists of interest income earned on investments and gains (losses) on foreign currency.

	Three months ended March 31,
	2023			2022			$ Change			% Change
	(dollars in thousands)
Change in fair value of warrant liabilities	$	57		$	264		$	(207	)		(78	%)
Interest expense		(2,331	)		(19	)		(2,312	)		12,168	%
Other income (expense), net		569			(64	)		633			989	%

The decrease in change in fair value of warrant liabilities during the three months ended March 31, 2023, as compared to three months ended March 31, 2022, primarily resulted from a relatively lower decline in our stock price during the quarter. The increase in interest expense was due to borrowings under the Term Loan during the three months ended March 31, 2023 compared to no borrowings outstanding during the three months ended March 31, 2022. The increase in other income was primarily due to higher interest income as a result of higher interest rates on our cash balances and increased foreign currency gains.

Income Tax (Provision) Benefit

Income tax (provision) benefit consists of income taxes related to U.S. federal and state jurisdictions as well as those foreign jurisdictions where we have business operations.

	Three months ended March 31,
	2023			2022		$ Change			% Change
	(dollars in thousands)
Income tax (provision) benefit	$	(48	)	$	706	$	(754	)		(107	%)

The income tax provision increase for the three months ended March 31, 2023, as compared to the three months ended March 31, 2022, was primarily driven by changes in our projected net deferred taxes after valuation allowance and a decrease in the net expense from discrete events.

28

Liquidity and Capital Resources

	Three months ended March 31,
	2023			2022
	(in thousands)
Net cash used in operating activities	$	(7,869	)	$	(33,371	)
Net cash used in investing activities		(3,417	)		(12,403	)
Net cash (used in) provided by financing activities		(2,441	)		1,923

As of March 31, 2023, we had cash and cash equivalents totaling $66.4 million.

Net cash used in operating activities was $7.9 million for the three months ended March 31, 2023 compared to $33.4 million for the three months ended March 31, 2022. The decrease in cash used in operating activities during the three months ended March 31, 2023, compared to the prior year quarter, was primarily due to a decrease in net loss as a result of lower headcount due to the Company's restructuring activities and as a result of reduced media spend in addition to a decrease in payments due to lower prior year payables. These decreases were partially offset by lower cash received from inventory sold.

Net cash used in investing activities was $3.4 million and $12.4 million for the three months ended March 31, 2023 and 2022, respectively. The decrease in net cash used in investing activities was due to the decrease in capital expenditures, in line with expectations.

Net cash used in financing activities was $2.4 million for the three months ended March 31, 2023 compared to net cash provided by financing activities of $1.9 million for the three months ended March 31, 2022. The change in net cash from financing activities was primarily due to taxes associated with the vesting of restricted stock during Q1 2023 and debt repayments on our Term Loan compared to proceeds from stock option exercises during Q1 2022.

On August 8, 2022, the Company, Beachbody, LLC, a Delaware limited liability company and wholly-owned direct subsidiary of the Company (the “Borrower”), and certain subsidiaries of the Company (together with the Company, the “Guarantors”), entered into a financing agreement (as amended, the “Financing Agreement”) with the lenders party thereto and Blue Torch Finance, LLC, as administrative agent and collateral agent for such lenders, providing for a senior secured term loan facility in an initial aggregate principal amount of $50.0 million (the “Term Loan”). Obligations under the Financing Agreement are guaranteed by the Guarantors, and secured by a lien on and security interest in substantially all of the assets of the Borrower and the Guarantors (together with the Borrower, the “Loan Parties”), subject to customary exceptions. As of March 31, 2023, our borrowings outstanding under the Term Loan were $49.1 million. During the three months ended March 31, 2023, the Term Loan was a SOFR loan, with a cash interest rate of 12.03%.

The Financing Agreement contains financial covenants that require us to maintain (a) certain minimum revenue levels, to be tested on a quarterly basis, and (b) minimum Liquidity (as defined in the Financing Agreement) of (i) $12.5 million at all times through June 30, 2023, and (ii) $15.0 million at all times thereafter through the maturity of the term loan facility. We were in compliance with these covenants as of March 31, 2023.

The Financing Agreement also contains customary representations, warranties, and covenants, which include, but are not limited to, restrictions on indebtedness, liens, fundamental changes, restricted payments, asset sales, affiliate transactions, changes in line of business, investments, negative pledges and amendments to organizational documents and material contracts. The Financing Agreement contains customary events of default, which among other things include (subject to certain exceptions and cure periods): failure to pay principal, interest, or any fees or certain other amounts when due; breach of any representation or warranty, covenant, or other agreement in the Financing Agreement and other related loan documents; the occurrence of a bankruptcy or insolvency proceeding with respect to any Loan Party; any failure by a Loan Party to make a payment with respect to indebtedness having an aggregate principal amount in excess of a specified threshold; and certain other customary events of default. See Note 9, Debt, for additional discussion of the Term Loan.

As of March 31, 2023, we have $35.9 million of lease obligations and purchase commitments associated with contracts that are enforceable and legally binding and that specify all significant terms, including fixed or minimum services to be used, fixed, minimum or variable price provisions, and the approximate timing of the actions under the contracts. See Note 8, Commitments and Contingencies, for discussion of our contractual commitments that are primarily due within the next year.

29

Our future capital requirements may vary materially from those currently planned and will depend on many factors, including our rate of revenue growth and overall economic conditions. We continue to assess and efficiently manage our working capital, and expect to generate additional liquidity through continued cost control initiatives. We believe that existing cash and cash equivalents and cost control initiatives will provide the Company with sufficient liquidity to meet our anticipated cash needs, including debt service requirements, for the next twelve months.

We may explore additional equity financing to supplement our anticipated working capital balances and further strengthen our financial position, but do not at this time know which form it will take or what the terms will be. The sale of additional equity would result in additional dilution to our shareholders. There can be no assurances that we will be able to raise additional capital in amounts or on terms acceptable to us.

Critical Accounting Policies and Estimates

There have been no material changes to the Company's critical accounting policies and estimates discussed in the 2022 Annual Report on Form 10-K in Item 7 under the heading Management's Discussion and Analysis of Financial Condition and Results of Operations - Critical Accounting Policies and Estimates.

Recent Accounting Pronouncements

See Note 1, Description of Business and Summary of Significant Accounting Policies, of the notes to our unaudited condensed consolidated financial statements included elsewhere in this Report for recently adopted accounting pronouncements and recently issued accounting pronouncements not yet adopted.

30

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

Foreign Currency Risk

We are exposed to foreign currency exchange risk related to transactions in currencies other than the U.S. Dollar, which is our functional currency. Our foreign subsidiaries, sales, certain inventory purchases and operating expenses expose us to foreign currency exchange risk. For the three months ended March 31, 2023 and 2022, approximately 10% of our revenue was in foreign currencies. These sales were primarily denominated in Canadian dollars and British pounds.

We use derivative instruments to manage the effects of fluctuations in foreign currency exchange rates on our net cash flows. We primarily enter into option contracts to hedge forecasted payments, typically for up to 12 months, for cost of revenue, selling and marketing expenses, general and administrative expenses and intercompany transactions not denominated in the local currencies of our foreign operations. We designate some of these instruments as cash flow hedges and record them at fair value as either assets or liabilities within the consolidated balance sheets. Some of these instruments are freestanding derivatives for which hedge accounting does not apply.

Changes in the fair value of cash flow hedges are recorded in accumulated other comprehensive income (loss) until the hedged forecasted transaction affects earnings. Deferred gains and losses associated with cash flow hedges of third-party payments are recognized in cost of revenue, selling and marketing or general and administrative expenses, as applicable, during the period when the hedged underlying transaction affects earnings. Changes in the fair value of certain derivatives for which hedge accounting does not apply are immediately recognized directly in earnings to cost of revenue.

A hypothetical 10% change in exchange rates, with the U.S. dollar as the functional and reporting currency, would not result in a material increase or decrease in cost of revenue and operating expenses due to the derivative instruments we use to hedge any foreign currency exposure.

The aggregate notional amount of foreign exchange derivative instruments at March 31, 2023 and year ended December 31, 2022 was $16.7 million and $17.6 million, respectively.

Item 4. Controls and Procedures.

Management’s Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of March 31, 2023. Based upon that evaluation, as a result of the material weaknesses identified in our 2022 Form 10-K, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of the end of the period covered by this Report.

Changes in Internal Control Over Financial Reporting

We continue to be in the process of implementing changes, as more fully described in our 2022 Form 10-K, to our internal control over financial reporting to remediate the material weaknesses as described in our 2022 Form 10-K.

There has been no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Limitations on Effectiveness of Controls and Procedures

Our disclosure controls and procedures are designed to provide reasonable assurance of achieving their objectives, as specified above. Our management recognizes that any control system, no matter how well designed and operated, is based upon certain judgements and assumptions and cannot provide absolute assurance that its objectives will be met.

PART II—OTHER INFORMATION

Item 1. Legal Proceedings.

We are and, from time to time, we may become, involved in legal proceedings or be subject to claims arising in the ordinary course of our business. There have been no material changes from the information previously reported under Part I, Item 3 of our Annual Report on Form 10-K for the fiscal year ended December 31, 2022.

31

Item 1A. Risk Factors.

Other than as set forth below, there have been no material developments with respect to the information previously reported under Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2022. These risk factors describe some of the assumptions, risks, uncertainties and other factors that could adversely affect our business or that could otherwise result in changes that differ materially from our expectations. We may disclose changes to such risk factors or disclose additional risk factors from time to time in our future filings with the SEC, including as set forth below.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Issuer Repurchase of Equity Securities.

None.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosure.

None.

Item 5. Other Information.

None.

32

Item 6. Exhibits.

Exhibit		Incorporated by Reference				Filed or Furnished herewith
		Form	Exhibit	Filing Date	File No.
2.1	Agreement and Plan of Merger, dated as of February 9, 2021, by and among Forest Road Acquisition Corp., BB Merger Sub, Inc., Myx Merger Sub, LLC, The Beachbody Company Group, LLC, And Myx Fitness Holdings, LLC.	8-K/A	2.1	2/16/2021	001-39735
3.1	Amended and Restated Certificate of Incorporation of The Beachbody Company, Inc.	8-K	3.1	7/1/2021	001-39735
3.2	Amended and Restated Bylaws of The Beachbody Company, Inc. (incorporated by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K filed July 1, 2021).	8-K	3.2	7/1/2021	001-39735
4.1	Form of Warrant.	10-Q	10.3	8/8/2022	001-39735
10.1	Financing Agreement, dated August 8, 2022, by and among Beachbody, LLC, a Delaware limited liability company, The Beachbody Company, Inc., a Delaware corporation (the “Parent”), each subsidiary of the Parent from time to time party thereto, the lenders from time to time party hereto (each a “Lender” and collectively, the “Lenders”), and Blue Torch Finance, LLC, as collateral agent and as administrative agent for the Lenders.	10-Q	10.2	8/8/2022	001-39735
10.2^	The Beachbody Company, Inc. Deferred Compensation Plan for Directors	10-K	10.10	3/16/2023	001-39735
10.3^	Offer of Employment Letter, dated September 27, 2021, by and between The Beachbody Company and Blake Bilstad.	10-Q	10.1	11/15/2021	001-39735
10.4^	Confidential Separation and General Release Agreement, dated as of March 10, 2023 and effective May 1, 2023, by and between Beachbody, LLC and Blake Bilstad.	10-K	10.15	3/16/2023	001-39735
31.1	Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and 15d-14(a)					*
31.2	Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and 15d-14(a)					*
32.1	Certification of Chief Executive Officer and Chief Financial Officer of Periodic Report Pursuant to 18 U.S.C. Section 1350					**
101.INS	Inline XBRL Instance Document					*
101.SCH	Inline XBRL Taxonomy Extension Schema Document					*
101.CAL	Inline XBRL Taxonomy Calculation Linkbase Document					*
101.DEF	Inline XBRL Taxonomy Definition Linkbase Document					*
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document					*
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document					*
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

* Filed herewith

** Furnished herewith.

^ Indicates management contract or compensatory plan.

33

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	The Beachbody Company, Inc.
Date: May 8, 2023	By:	/s/ Carl Daikeler
		Carl Daikeler
		Chief Executive Officer
		(Principal Executive Officer)
Date: May 8, 2023	By:	/s/ Marc Suidan
		Marc Suidan
		Chief Financial Officer
		(Principal Financial Officer)

34

EX-31

Exhibit 31.1

CERTIFICATION PURSUANT TO

RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Carl Daikeler, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of The Beachbody Company, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal controls over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 8, 2023	By:	/s/ Carl Daikeler
		Carl Daikeler
		Chief Executive Officer (Principal Executive Officer)

EX-31

Exhibit 31.2

CERTIFICATION PURSUANT TO

RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Marc Suidan, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of The Beachbody Company, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal controls over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 8, 2023	By:	/s/ Marc Suidan
		Marc Suidan
		Chief Financial Officer (Principal Financial Officer)

EX-32

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of The Beachbody Company, Inc. (the “Company”) on Form 10-Q for the period ending March 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: May 8, 2023	By:	/s/ Carl Daikeler
		Carl Daikeler
		Chief Executive Officer (Principal Executive Officer)

In connection with the Quarterly Report of The Beachbody Company, Inc. (the “Company”) on Form 10-Q for the period ending March 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: May 8, 2023	By:	/s/ Marc Suidan
		Marc Suidan
		Chief Financial Officer (Principal Financial Officer)

XML

Cover Page - shares	3 Months Ended
	Mar. 31, 2023	May 02, 2023
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Mar. 31, 2023
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
Entity Registrant Name	The Beachbody Company, Inc.
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Central Index Key	0001826889
Entity File Number	001-39735
Entity Tax Identification Number	85-3222090
Entity Incorporation, State or Country Code	DE
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Address, Address Line One	400 Continental Blvd
Entity Address, Address Line Two	Suite 400
Entity Address, City or Town	El Segundo,
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	90245
City Area Code	310
Local Phone Number	883-9000
Entity Shell Company	false
Common Class A [Member]
Document Information [Line Items]
Title of 12(b) Security	Class A Common Stock, par value $0.0001 per share
Trading Symbol	BODY
Security Exchange Name	NYSE
Entity Common Stock, Shares Outstanding		177,193,226
Redeemable Warrants [Member]
Document Information [Line Items]
Title of 12(b) Security	Redeemable warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50
Trading Symbol	BODY WS
Security Exchange Name	NYSE
Common Class X [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		141,250,310

XML

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 66,393	$ 80,091
Inventory, net	48,304	54,060
Prepaid expenses	11,403	13,055
Other current assets	45,687	39,248
Total current assets	171,787	186,454
Property and equipment, net	67,395	74,147
Content assets, net	31,551	34,888
Goodwill	125,166	125,166
Intangible assets, net	6,926	8,204
Right-of-use assets, net	4,520	5,030
Other assets	8,428	9,506
Total assets	415,773	443,395
Current liabilities:
Accounts payable	16,754	17,940
Accrued expenses	54,784	64,430
Deferred revenue	99,894	95,587
Current portion of lease liabilities	2,100	2,150
Current portion of Term Loan	1,250	1,250
Other current liabilities	3,513	3,283
Total current liabilities	178,295	184,640
Term Loan	40,276	39,735
Long-term lease liabilities, net	2,794	3,318
Deferred tax liabilities	172	181
Other liabilities	4,679	3,979
Total liabilities	226,216	231,853
Commitments and contingencies (Note 8)
Stockholders' equity:
Preferred stock, $0.0001 par value; 100,000,000 shares authorized, none issued and outstanding at March 31, 2023 and December 31, 2022
Additional paid-in capital	638,135	630,709
Accumulated deficit	(448,423)	(419,235)
Accumulated other comprehensive income (loss)	(187)	37
Total stockholders' equity	189,557	211,542
Total liabilities and stockholders' equity	415,773	443,395
Class A Common Stock [Member]
Stockholders' equity:
Common stock value	18	17
Class X Common Stock [Member]
Stockholders' equity:
Common stock value	14	14
Class C Common Stock [Member]
Stockholders' equity:
Common stock value

XML

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2023	Dec. 31, 2022
Preferred stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	100,000,000	100,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	1,900,000,000	1,900,000,000
Class A Common Stock [Member]
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	1,600,000,000	1,600,000,000
Common stock, shares issued	177,004,131	170,911,819
Common stock, shares outstanding	177,004,131	170,911,819
Class X Common Stock [Member]
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	200,000,000	200,000,000
Common stock, shares issued	141,250,310	141,250,310
Common stock, shares outstanding	141,250,310	141,250,310
Class C Common Stock [Member]
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	0	0
Common stock, shares outstanding	0	0

XML

Unaudited Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Revenue:
Revenue	$ 144,901	$ 198,922
Cost of revenue:
Cost of revenue	53,561	105,905
Gross Profit	91,340	93,017
Operating expenses:
Selling and marketing	76,576	106,444
Enterprise technology and development	19,096	33,697
General and administrative	17,716	20,073
Restructuring	5,387	7,223
Total operating expenses	118,775	167,437
Operating loss	(27,435)	(74,420)
Other income (expense):
Change in fair value of warrant liabilities	57	264
Interest expense	(2,331)	(19)
Other income (expense), net	569	(64)
Loss before income taxes	(29,140)	(74,239)
Income tax (provision) benefit	(48)	706
Net loss	$ (29,188)	$ (73,533)
Net loss per common share, basic	$ (0.09)	$ (0.24)
Net loss per common share, diluted	$ (0.09)	$ (0.24)
Weighted-average common shares outstanding- basic	309,140,558	306,362,730
Weighted-average common shares outstanding- diluted	309,140,558	306,362,730
Digital [Member]
Revenue:
Revenue	$ 64,773	$ 81,745
Cost of revenue:
Cost of revenue	14,967	16,425
Connected Fitness [Member]
Revenue:
Revenue	6,008	19,513
Cost of revenue:
Cost of revenue	7,555	44,706
Nutrition And Other [Member]
Revenue:
Revenue	74,120	97,664
Cost of revenue:
Cost of revenue	$ 31,039	$ 44,774

XML

Unaudited Condensed Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Statement of Comprehensive Income [Abstract]
Net loss	$ (29,188)	$ (73,533)
Other comprehensive income (loss):
Change in fair value of derivative financial instruments, net of tax	(147)	(185)
Reclassification of (losses) gains on derivative financial instruments included in net loss	(87)	69
Foreign currency translation adjustment	10	4
Total other comprehensive loss	(224)	(112)
Total comprehensive loss	$ (29,412)	$ (73,645)

XML

Unaudited Condensed Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings (Accumulated Deficit) [Member]	Accumulated Other Comprehensive Income (Loss) [Member]
Beginning balance at Dec. 31, 2021	$ 385,385	$ 31	$ 610,418	$ (225,043)	$ (21)
Beginning balance, Shares at Dec. 31, 2021		309,584
Net loss	(73,533)			(73,533)
Other comprehensive income (loss)	(112)				(112)
Equity-based compensation	4,564		4,564
Options exercised, net of tax withholdings	1,923		1,923
Options exercised, net of tax withholdings, Shares		1,132
Ending balance at Mar. 31, 2022	318,227	$ 31	616,905	(298,576)	(133)
Ending balance, shares at Mar. 31, 2022		310,716
Beginning balance at Dec. 31, 2022	211,542	$ 31	630,709	(419,235)	37
Beginning balance, Shares at Dec. 31, 2022		312,162
Net loss	(29,188)			(29,188)
Other comprehensive income (loss)	(224)				(224)
Equity-based compensation	9,555	$ 1	9,554
Equity-based compensation, Shares		9,736
Shares withheld for tax withholdings on vesting of restricted stock	(2,128)		(2,128)
Shares withheld for tax withholdings on vesting of restricted stock, Shares		(3,644)
Ending balance at Mar. 31, 2023	$ 189,557	$ 32	$ 638,135	$ (448,423)	$ (187)
Ending balance, shares at Mar. 31, 2023		318,254

XML

Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net loss	$ (29,188)	$ (73,533)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense	10,713	21,587
Amortization of content assets	5,561	6,164
Provision for inventory and inventory purchase commitments	2,734	16,896
Realized gains (losses) on hedging derivative financial instruments	(87)	69
Change in fair value of warrant liabilities	(57)	(264)
Equity-based compensation	9,555	4,564
Deferred income taxes	(53)	(808)
Amortization of Debt Issuance Costs	479
Paid-in-kind interest expense	374
Other non-cash items		91
Changes in operating assets and liabilities:
Inventory	3,056	15,887
Content assets	(2,224)	(6,448)
Prepaid expenses	1,652	(293)
Other assets	(4,958)	2,895
Accounts payable	(1,366)	(20,752)
Accrued expenses	(8,768)	(1,386)
Deferred revenue	4,746	2,370
Other liabilities	(38)	(410)
Net cash used in operating activities	(7,869)	(33,371)
Cash flows from investing activities:
Purchase of property and equipment	(3,417)	(12,403)
Net cash used in investing activities	(3,417)	(12,403)
Cash flows from financing activities:
Proceeds from exercise of stock options		2,115
Remittance of taxes withheld from employee stock awards		(192)
Debt repayments	(313)
Tax withholding payments for vesting of restricted stock	(2,128)
Net cash (used in) provided by financing activities	(2,441)	1,923
Effect of exchange rates on cash	29	223
Net decrease in cash and cash equivalents	(13,698)	(43,628)
Cash, cash equivalents and restricted cash, beginning of period	80,091	107,054
Cash, cash equivalents and restricted cash, end of period	66,393	63,426
Supplemental disclosure of cash flow information:
Cash paid during the period for interest	1,464	10
Cash (received) paid during the year for income taxes, net	(265)	32
Supplemental disclosure of noncash investing activities:
Property and equipment acquired but not yet paid for	$ 1,291	$ 4,225

XML

Description Of Business And Summary Of Significant Accounting Policies

3 Months Ended

Mar. 31, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Description Of Business And Summary Of Significant Accounting Policies

1. Description of Business and Summary of Significant Accounting Policies

Business

The Beachbody Company, Inc. (“Beachbody” or the “Company”) is a leading subscription health and wellness company and the creator of some of the world’s most popular fitness programs. The Company’s fitness programs are available for streaming through subscription to Beachbody On Demand (“BOD”) and, together with the Company’s live fitness and comprehensive nutrition programs, through subscription to Beachbody On Demand Interactive (“BODi”). During the three months ended March 31, 2023, the Company launched an improved BODi experience and began migrating all BOD-only members to BODi on their renewal dates. Beachbody offers nutritional products such as Shakeology nutrition shakes, BEACHBAR snack bars, and Ladder premium supplements, which have been designed and clinically tested to help customers achieve their goals. Beachbody also offers a professional-grade stationary cycle with a 360-degree touch screen tablet and connected fitness software. The Company’s revenue has historically been generated primarily through a network of micro-influencers (“Partners”) (previously known as “Coaches”), social media marketing channels, and direct response advertising. References to “Coaches” throughout this report have been updated to “Partners.”

Basis of Presentation and Principles of Consolidation

The Company prepares its consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information as determined by the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) and pursuant to the regulations of the U.S. Securities and Exchange Commission (“SEC”).

The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that impact the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Significant estimates include, but are not limited to, the useful life and recoverability of long-lived assets, the valuation of warrant liabilities, the recognition and measurement of income tax assets and liabilities, the valuation of intangible assets, impairment of goodwill, and the net realizable value of inventory. The Company bases these estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgements about the carrying amounts of assets and liabilities. Actual results could differ from those estimates.

The unaudited condensed consolidated financial statements have been prepared on the same basis as the annual audited consolidated financial statements and, in the opinion of management, include all normal recurring adjustments necessary for the fair statement of the Company’s financial position, results of operations, and cash flows. The financial data and other financial information disclosed in the notes to these unaudited condensed consolidated financial statements are also unaudited. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the related notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. Interim results are not necessarily indicative of the results expected for the full fiscal year or any other period.

Recently Adopted Accounting Pronouncements

In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which requires an acquirer to apply ASC 606 to recognize and measure contract assets and liabilities from contracts with customers acquired in a business combination on the acquisition date rather than the general guidance in ASC 805. The Company adopted this new accounting guidance on a prospective basis on January 1, 2023, and the adoption did not have a material effect on its unaudited condensed consolidated financial statements.

In September 2022, the FASB issued ASU 2022-04, Liabilities-Supplier Finance Programs (Topic 405-50) - Disclosure of Supplier Finance Program Obligations, which requires that a buyer in a supplier finance program disclose sufficient information about the program to allow a user of financial statements to understand the program’s nature, activity during the period, changes from period to period, and potential magnitude. The Company adopted this new accounting guidance on a prospective basis on January 1, 2023, and the adoption did not have a material effect on its unaudited condensed consolidated financial statements.

XML

Revenue

3 Months Ended

Mar. 31, 2023

Revenue from Contract with Customer [Abstract]

Revenue

2. Revenue

The Company’s revenue disaggregated by geographic region is as follows (in thousands):

	Three months ended March 31,
	2023		2022
Geographic region:
United States	$	130,877	$	178,607
Rest of world1		14,024		20,315
Total revenue	$	144,901	$	198,922

(1) Consists of Canada, United Kingdom, and France. No single country accounted for more than 10% of total revenue during the three months ended March 31, 2023 and 2022.

The Company determined that, in addition to the preceding table, the disaggregation of revenue by revenue type as presented in the unaudited condensed consolidated statements of operations achieves the disclosure requirement to disaggregate revenue into categories that depict how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors.

Deferred Revenue

Deferred revenue is recorded for nonrefundable cash payments received for the Company’s performance obligation to transfer, or stand ready to transfer, goods or services in the future. Deferred revenue consists of subscription fees billed that have not been recognized and physical products sold that have not yet been delivered. During the three months ended March 31, 2023, the Company recognized $53.1 million of revenue that was included in the deferred revenue balance as of December 31, 2022. During the three months ended March 31, 2022, the Company recognized $62.5 million of revenue that was included in the deferred revenue balance as of December 31, 2021.

XML

Fair Value Measurements

3 Months Ended

Mar. 31, 2023

Fair Value Disclosures [Abstract]

Fair Value Measurements

3. Fair Value Measurements

The Company’s financial assets and liabilities subject to fair value measurements on a recurring basis and the level of inputs used for such measurements were as follows (in thousands):

	March 31, 2023
	Level 1		Level 2		Level 3
Assets
Derivative assets	$	—	$	249	$	—
Total assets	$	—	$	249	$	—
Liabilities
Public warrants	$	600	$	—	$	—
Private placement warrants		—		—		53
Term Loan warrants		—		—		1,038
Total liabilities	$	600	$	—	$	1,091
	December 31, 2022
	Level 1		Level 2		Level 3
Assets
Derivative assets	$	—	$	462	$	—
Total assets	$	—	$	462	$	—
Liabilities
Public Warrants	$	415	$	—	$	—
Private Placement Warrants		—		—		107
Term Loan Warrants		—		—		1,226
Total liabilities	$	415	$	—	$	1,333

Fair values of cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses approximate the recorded value due to the short period of time to maturity. The fair value of the public warrants, which trade in active markets, is based on quoted market prices. The fair value of derivative instruments is based on Level 2 inputs such as observable forward rates, spot rates, and foreign currency exchange rates. The Company’s private placement and Term Loan warrants are classified within Level 3 of the fair value hierarchy because their fair values are based on significant inputs that are unobservable in the market.

Private Placement Warrants

The Company determined the fair value of the private placement warrants using a Black-Scholes option-pricing model and the quoted price of the Company’s Class A Common Stock. Volatility was based on the implied volatility derived primarily from the average of the actual market activity of the Company’s peer group. The expected life was based on the remaining contractual term of the private placement warrants, and the risk-free interest rate was based on the implied yield available on U.S. treasury securities with a maturity equivalent to the warrants’ expected life. The significant unobservable input used in the fair value measurement of the private placement warrants is the implied volatility. Significant changes in the implied volatility would result in a significantly higher or lower fair value measurement, respectively.

The following table presents significant assumptions utilized in the valuation of the private placement warrants on March 31, 2023 and December 31, 2022:

	March 31, 2023			December 31, 2022
Risk-free rate		3.8	%		4.2	%
Dividend yield rate		—			—
Volatility		75.0	%		75.0	%
Contractual term (in years)		3.24			3.49
Exercise price	$	11.50		$	11.50

The following table presents changes in the fair value of the private placement warrants for the three months ended March 31, 2023 and 2022 (in thousands):

	Three months ended March 31,
	2023			2022
Balance, beginning of period	$	107		$	2,133
Change in fair value		(54	)		(213	)
Balance, end of period	$	53		$	1,920

For the three months ended March 31, 2023 and 2022, the change in the fair value of private placement warrants resulted from the change in price of the Company’s Class A Common Stock, remaining contractual term, and risk-free rate. The changes in fair value are included in the unaudited condensed consolidated statements of operations as a component of change in fair value of warrant liabilities and in the unaudited condensed consolidated balance sheets as other liabilities.

Term Loan Warrants

The Company determined the fair value of the Term Loan warrants using a Black-Scholes option-pricing model and the quoted price of the Company’s Class A Common Stock. Volatility was based on the implied volatility derived primarily from the average of the actual market activity of the Company’s peer group. The expected life was based on the remaining contractual term of the Term Loan warrants, and the risk-free interest rate was based on the implied yield available on U.S. treasury securities with a maturity equivalent to the warrants’ expected life. The significant unobservable input used in the fair value measurement of the Term Loan warrants is the implied volatility. Significant changes in the implied volatility would result in a significantly higher or lower fair value measurement, respectively. See Note 9, Debt, for additional information regarding the Term Loan warrants.

The following table presents significant assumptions utilized in the valuation of the Term Loan Warrants at March 31, 2023 and December 31, 2022:

	March 31, 2023			December 31, 2022
Risk-free rate		3.6	%		4.0	%
Dividend yield rate		—			—
Volatility		75.0	%		75.0	%
Contractual term (in years)		6.36			6.61
Exercise price	$	1.85		$	1.85

The following table presents changes in the fair value of the Term Loan warrants for the three months ended March 31, 2023 and 2022 (in thousands):

	Three months ended March 31,
	2023			2022
Balance, beginning of period	$	1,226		$	—
Change in fair value		(188	)		—
Balance, end of period	$	1,038		$	—

XML

Inventory, Net

3 Months Ended

Mar. 31, 2023

Inventory Disclosure [Abstract]

Inventory, Net

4. Inventory, Net

Inventory, net consists of the following (in thousands):

	March 31, 2023		December 31, 2022
Raw materials and work in process	$	12,620	$	13,380
Finished goods		35,684		40,680
Total inventory, net	$	48,304	$	54,060

Adjustments to the carrying value of excess inventory and inventory on hand to net realizable value were $2.7 million and $16.9 million during the three months ended March 31, 2023 and 2022, respectively. These adjustments are included in the unaudited condensed consolidated statements of operations as a component of nutrition and other cost of revenue and connected fitness cost of revenue. The Company recorded $1.3 million and $2.5 million in nutrition and other cost of revenue for the three months ended March 31, 2023 and 2022, respectively, and $1.4 million and $14.4 million in connected fitness cost of revenue for the three months ended March 31, 2023 and 2022, respectively.

XML

Other Current Assets

3 Months Ended

Mar. 31, 2023

Other Current Assets [Abstract]

Other Current Assets

5. Other Current Assets

Other current assets consist of the following (in thousands):

	March 31, 2023		December 31, 2022
Deferred partner costs	$	35,301	$	31,270
Deposits		5,876		4,527
Accounts receivable, net		1,839		866
Other		2,671		2,585
Total other current assets	$	45,687	$	39,248

XML

Property and Equipment, Net

9 Months Ended

Sep. 30, 2022

Property, Plant and Equipment [Abstract]

Property and Equipment, Net

6. Property and Equipment, Net

Property and equipment, net consists of the following (in thousands):

	March 31, 2023			December 31, 2022
Computer software and web development	$	224,851		$	236,533
Computer equipment		23,452			24,240
Buildings		5,158			5,158
Leasehold improvements		4,600			4,600
Furniture, fixtures and equipment		1,207			1,222
Computer software and web development projects in-process		7,028			5,147
Property and equipment, gross		266,296			276,900
Less: Accumulated depreciation		(198,901	)		(202,753	)
Total property and equipment, net	$	67,395		$	74,147

The Company recorded depreciation expense related to property and equipment in the following expense categories of its unaudited condensed consolidated statements of operations as follows (in thousands):

	Three months ended March 31,
	2023		2022
Cost of revenue	$	4,932	$	9,081
Selling and marketing		—		279
Enterprise technology and development		4,503		7,449
General and administrative		1		192
Total depreciation	$	9,436	$	17,001

XML

Accrued Expenses

3 Months Ended

Mar. 31, 2023

Payables and Accruals [Abstract]

Accrued Expenses

7. Accrued Expenses

Accrued expenses consist of the followings (in thousands):

	March 31, 2023		December 31, 2022
Inventory, shipping and fulfillment	$	13,233	$	11,687
Partner costs		13,047		14,535
Employee compensation and benefits		10,610		20,584
Sales and other taxes		4,891		4,818
Information technology		2,545		2,207
Advertising		1,773		1,176
Customer service expenses		790		956
Other accrued expenses		7,895		8,467
Total accrued expenses	$	54,784	$	64,430

Advertising costs, which are primarily comprised of social media, television media, and internet advertising expenses and also include print, radio, and infomercial production costs, were $9.0 million and $15.8 million for the three months ended March 31, 2023 and 2022, respectively.

XML

Commitments and Contingencies

3 Months Ended

Mar. 31, 2023

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

8. Commitments and Contingencies

Inventory Purchase and Service Agreements

The Company has noncancelable inventory purchase and service agreements with multiple service providers which expire at varying dates through 2028. Service agreement obligations include amounts related to fitness and nutrition trainers, future events, information systems support, and other technology projects.

Future minimum payments under noncancelable service and inventory purchase agreements for the periods succeeding March 31, 2023 are as follows (in thousands):

Nine months ending December 31, 2023	$	26,651
Year ending December 31, 2024		2,039
Year ending December 31, 2025		1,475
Year ending December 31, 2026		100
Year ending December 31, 2027		75
Thereafter		75
	$	30,415

The preceding table excludes royalty payments to fitness trainers, talent, and others that are based on future sales as such amounts cannot be reasonably estimated.

Lease Commitments

The Company leases facilities under noncancelable operating leases expiring through 2027 and certain equipment under a finance lease expiring in 2024. These lease obligations will require payments of approximately $1.8 million during the nine months ending December 31, 2023 and $3.6 million for the year ending December 31, 2024 and thereafter through 2027.

Contingencies

The Company is subject to litigation from time to time in the ordinary course of business. Such claims typically involve its products, intellectual property, and relationships with suppliers, customers, distributors, employees, and others. Contingent liabilities are recorded when it is both probable that a loss has occurred and the amount of the loss can be reasonable estimated. Although it is not possible to predict how litigation and other claims will be resolved, the Company does not believe that any currently identified claims or litigation matters will have a material adverse effect on its consolidated financial position or results of operations.

XML

Debt

3 Months Ended

Mar. 31, 2023

Debt Disclosure [Abstract]

Debt

9. Debt

On August 8, 2022 (the “Effective Date”), the Company, Beachbody, LLC as borrower (a wholly owned subsidiary of the Company), and certain other subsidiaries of the Company as guarantors on the signature pages (the “Guarantors”), the lenders (the “Lenders”), and Blue Torch Finance, LLC, as administrative agent and collateral agent for such lenders (the “Term Loan Agent”) entered into a financing agreement (the “Financing Agreement”). The Financing Agreement provides for senior secured term loans on the Effective Date in an aggregate principal amount of $50.0 million (the “Term Loan”) which was drawn on the Effective Date. In addition, the Financing Agreement permits the Company to borrow up to an additional $25.0 million, subject to the terms and conditions set forth in the Financing Agreement. Borrowings under the Term Loan are unconditionally guaranteed by the Guarantors, and all present and future material U.S. and Canadian subsidiaries of the Company. Such security interest consists of a first-priority perfected lien on substantially all property and assets of the Company and subsidiaries, including stock pledges on the capital stock of the Company’s material and direct subsidiaries, subject to customary carveouts. In connection with the Financing Agreement, the Company incurred $4.2 million of third-party debt issuance costs which are recorded in the unaudited condensed consolidated balance sheets as a reduction of long-term debt as of March 31, 2023 and December 31, 2022 and are being amortized over the term of the Term Loan using the effective-interest method. As of March 31, 2023, borrowings outstanding under the Term Loan were $49.1 million. The Term Loan matures on August 8, 2026.

The Term Loan borrowings may take the form of base rate (“Reference Rate”) loans or Secured Overnight Financing Rate (“SOFR”) loans. Reference Rate loans bear interest at a rate per annum equal to the sum of an applicable margin of 6.15% per annum, plus the greater of (a) 2.00% per annum, (b) the Federal Funds Rate plus 0.50% per annum, (c) the “SOFR Rate” (based upon an interest period of 1 month) plus 1.00% per annum, and (d) the rate last quoted by The Wall Street Journal. SOFR loans bear interest at a rate per annum equal to the sum of an applicable margin of 7.15% and the “SOFR Rate” (based upon an interest period of 3 months). The “SOFR Rate” is subject to a floor of 1.00%. In addition, the Term Loan borrowings bear additional interest at 3.00% per annum, paid in kind by capitalizing such interest and adding such capitalized interest to the outstanding principal amount of the loans on each anniversary of the Effective Date. The $50.0 million Term Loan was a SOFR loan, with a cash interest rate of 12.03%. The Company recorded $2.3 million of interest related to the Term Loan during the three months ended March 31, 2023.

The Financing Agreement contains financial covenants that require us to maintain (a) certain minimum revenue levels, to be tested on a quarterly basis, and (b) minimum Liquidity (as defined in the Financing Agreement) of (i) $12.5 million at all times through June 30, 2023, and (ii) $15.0 million at all times thereafter through the maturity of the term loan facility. We were in compliance with these covenants as of March 31, 2023.

In connection with the Term Loan, the Company issued to certain holders affiliated with Blue Torch Finance, LLC warrants for the purchase of 4,716,756 shares of the Company’s Class A Common Stock at an exercise price of $1.85 per share. The warrants vest on a monthly basis over four years, with 30%, 30%, 20% and 20% vesting in the first, second, third and fourth years, respectively. The warrants have a seven-year term from the Effective Date. See Note 3, Fair Value Measurements, for information on the valuation of the warrants. The warrants were recorded in the unaudited condensed consolidated balance sheets as warrant liabilities. The initial fair value of the warrants, of $5.2 million, is being amortized as a debt discount over the term of the Term Loan using the effective-interest method.

The aggregate amounts of payments due for the periods succeeding March 31, 2023 and reconciliation of the Company’s debt balances, net of debt discount and debt issuance costs, are as follows (in thousands):

Nine months ending December 31, 2023	$	937
Year ending December 31, 2024		1,563
Year ending December 31, 2025		2,500
Year ending December 31, 2026		44,063
Total debt	$	49,063
Less current portion		(1,250	)
Less unamortized debt discount and debt issuance costs		(8,509	)
Add capitalized paid-in-kind interest		972
Total long-term debt	$	40,276

The Term Loan amortizes at 2.50% per year from the Effective Date to the date that is the second anniversary of the Effective Date, payable on a quarterly basis, and thereafter, at 5.00% per year, payable on a quarterly basis. The Financing Agreement contains certain customary covenants, including minimum revenue, with which the Company was in compliance as of March 31, 2023.

XML

Stockholders' Equity

3 Months Ended

Mar. 31, 2023

Stockholders' Equity Note [Abstract]

Stockholders' Equity

10. Stockholders’ Equity

As of March 31, 2023, 2,000,000,000 shares, $0.0001 par value per share are authorized, of which, 1,600,000,000 shares are designated as Class A Common Stock, 200,000,000 shares are designated as Class X Common Stock, 100,000,000 shares are designated as Class C Common Stock and 100,000,000 shares are designated as Preferred Stock.

Holders of each share of each class of Common Stock are entitled to dividends when, as, and if declared by the Company’s board of directors, subject to the rights and preferences of any holders of Preferred Stock outstanding at the time. The holder of each Class A Common Stock is entitled to one vote, the holder of each share of Class X Common Stock is entitled to ten votes and except as otherwise required by law, the holder of each share of Class C Common Stock is not entitled to any voting powers.

Accumulated Other Comprehensive Income (Loss)

The following tables summarize changes in accumulated other comprehensive income (loss) by component during the three months ended March 31, 2023 and 2022 (in thousands):

	Unrealized Gain (Loss) on Derivatives			Foreign Currency Translation Adjustment			Total
Balances at December 31, 2021	$	(32	)	$	11		$	(21	)
Other comprehensive loss before reclassifications		(162	)		4			(158	)
Amounts reclassified from accumulated other comprehensive income (loss)		69			—			69
Tax effect		(23	)		—			(23	)
Balances at March 31, 2022	$	(148	)	$	15		$	(133	)
Balances at December 31, 2022	$	131		$	(94	)	$	37
Other comprehensive loss before reclassifications		(101	)		10			(91	)
Amounts reclassified from accumulated other comprehensive income (loss)		(87	)		—			(87	)
Tax effect		(46	)		—			(46	)
Balances at March 31, 2023	$	(103	)	$	(84	)	$	(187	)

XML

Equity-Based Compensation

3 Months Ended

Mar. 31, 2023

Share-Based Payment Arrangement [Abstract]

Equity-Based Compensation

11. Equity-Based Compensation

Equity Compensation Plans

A summary of the option activity under the Company’s equity compensation plans is as follows:

	Options Outstanding
	Number of Options			Weighted-Average Exercise Price (per option)		Weighted-Average Remaining Contractual Term (in years)		Aggregate Intrinsic Value (in thousands)
Outstanding at December 31, 2022		48,414,625		$	2.65		6.35	$	—
Granted		3,463,488			0.63
Forfeited		(3,272,682	)		2.80
Expired		(496,499	)		2.54
Outstanding at March 31, 2023		48,108,932		$	2.49		5.91	$	—
Exercisable at March 31, 2023		23,015,721		$	2.48		2.86	$	—

A summary of RSU activity is as follows:

	RSUs Outstanding
	Number of RSUs			Weighted-Average Fair Value (per RSU)
Outstanding at December 31, 2022		3,159,185		$	1.45
Granted		22,676,189			0.58
Vested		(9,736,133	)		0.60
Forfeited		(619,173	)		0.96
Outstanding at March 31, 2023		15,480,068		$	0.73

The fair value of RSUs vested during the three months ended March 31, 2023 was $5.9 million. No RSUs vested during the three months ended March 31, 2022.

On January 1, 2023, the number of shares available for issuance under the 2021 Incentive Award Plan (the “2021 Plan”) increased by 15,608,106 pursuant to the terms of the 2021 Plan. As of March 31, 2023, 11,663,071 shares of Class A Common Stock were available for issuance under the 2021 Plan.

Vested RSUs included shares of common stock that the Company withheld on behalf of certain employees to satisfy the minimum statutory tax withholding requirements, as defined by the Company. The Company withheld shares of common stock with an aggregate fair value and remitted taxes of $2.1 million during the three months ended March 31, 2023, which were classified as financing cash outflows in the unaudited condensed consolidated statements of cash flows. The Company canceled and returned these shares to the 2021 Plan, which are available under the plan terms for future issuance.

Equity-Based Compensation Expense

The fair value of each award as of the date of grant is estimated using a Black-Scholes option-pricing model. The following table summarizes the weighted-average assumptions used to determine the fair value of option grants:

	Three months ended March 31,
	2023			2022
Risk-free rate		3.6	%		1.7	%
Dividend yield rate		—			—
Volatility		56.4	%		52.3	%
Expected term (in years)		5.16			6.20
Weighted-average grant date fair value	$	0.32		$	0.95

Equity-based compensation expense for the three months ended March 31, 2023 and 2022 was as follows (in thousands):

	Three months ended March 31,
	2023		2022
Cost of revenue	$	1,429	$	335
Selling and marketing		3,386		1,639
Enterprise technology and development		563		927
General and administrative		4,177		1,663
Total equity-based compensation	$	9,555	$	4,564

In connection with the restructuring activity that took place during the three months ended March 31, 2023, the Company modified certain stock awards of terminated employees (approximately 102 employees). The modifications included; accelerating the vesting of any options that would have vested within three months of the employees termination date; and all vested options will be available for exercise for a total of six months after the employees’ termination date (that is, three months in addition to the standard three months per original agreement). As a result of these modifications, the Company recognized a $0.6 million reduction to equity-based compensation expense within general and administrative expense in the unaudited condensed consolidated statements of operations.

As of March 31, 2023, the total unrecognized equity-based compensation expense was $38.8 million, which will be recognized over a weighted-average remaining period of 2.88 years.

XML

Derivative Financial Instruments

3 Months Ended

9 Months Ended

Mar. 31, 2023

Sep. 30, 2022

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Financial Instruments

12. Derivative Financial Instruments

As of March 31, 2023 and December 31, 2022, the notional amount of the Company’s outstanding foreign exchange options was $16.7 million and $17.6 million, respectively. There were no outstanding forward contracts as of March 31, 2023 and December 31, 2022.

The following table shows the pre-tax effects of the Company’s derivative instruments on its unaudited condensed consolidated statements of operations (in thousands):

		Three months ended March 31,
	Financial Statement Line Item	2023			2022
Unrealized gains (losses)	Other comprehensive income (loss)	$	(101	)	$	(162	)
Gains (losses) reclassified from accumulated other	Cost of revenue	$	36		$	(30	)
comprehensive income into net loss	General and administrative		51			(39	)
Total amounts reclassified		$	87		$	(69	)
Gains (losses) recognized on derivatives   not designated as hedging instruments	Cost of revenue	$	(41	)	$	(51	)

. Derivative Financial Instruments

As of March 31, 2023 and December 31, 2022, the notional amount of the Company’s outstanding foreign exchange options was $16.7 million and $17.6 million, respectively. There were no outstanding forward contracts as of March 31, 2023 and December 31, 2022.

The following table shows the pre-tax effects of the Company’s derivative instruments on its unaudited condensed consolidated statements of operations (in thousands):

		Three months ended March 31,
	Financial Statement Line Item	2023			2022
Unrealized gains (losses)	Other comprehensive income (loss)	$	(101	)	$	(162	)
Gains (losses) reclassified from accumulated other	Cost of revenue	$	36		$	(30	)
comprehensive income into net loss	General and administrative		51			(39	)
Total amounts reclassified		$	87		$	(69	)
Gains (losses) recognized on derivatives   not designated as hedging instruments	Cost of revenue	$	(41	)	$	(51	)

XML

Restructuring

3 Months Ended

Mar. 31, 2023

Restructuring and Related Activities [Abstract]

Restructuring

13. Restructuring

In 2023, restructuring charges primarily relate to activities focused on aligning the Company's operations with its key growth priorities. Restructuring charges in 2022 relate to the consolidation of our streaming fitness and nutrition offerings into a single Beachbody platform. The Company recognized restructuring costs of $5.4 million and $7.2 million during the three months ended March 31, 2023 and 2022, respectively, comprised primarily of termination benefits related to headcount reductions, of which $1.4 million is included in accrued expenses in the unaudited condensed consolidated balance sheets. In accordance with GAAP, employee termination benefits were recognized at the date employees were notified and post-employment benefits were accrued as the obligation was probable and estimable. Benefits for employees who provided service greater than 60 days from the date of notification were recognized ratably over the service period.

The following table summarizes activity in the Company’s restructuring-related liability during the three months ended March 31, 2023 (in thousands):

	Balance at		Restructuring		Payments /			Liability at
	December 31, 2022		Charges		Utilizations			March 31, 2023
Employee-related costs	$	469	$	5,387	$	(4,467	)	$	1,389
Total costs	$	469	$	5,387	$	(4,467	)	$	1,389

The Company expects to incur additional charges of approximately $0.2 million related to termination benefits as it fully implements its strategic alignment initiative.

XML

Income Taxes

3 Months Ended

Mar. 31, 2023

Income Tax Disclosure [Abstract]

Income Taxes

14. Income Taxes

The Company recorded a provision for income taxes of approximately zero for the three months ended March 31, 2023, and a benefit for income taxes of $0.7 million for the three months ended March 31, 2022. The effective tax rate was (0.2)% for the three months ended March 31, 2023, and the effective benefit tax rate was 1.0% for the three months ended March 31, 2022.

The tax provision for interim periods is determined using an estimate of the Company’s annual effective tax rate, adjusted for discrete items arising in that quarter. The Company’s effective tax rate differs from the U.S. statutory tax rate in the three months ended March 31, 2023 primarily due to changes in valuation allowances on deferred tax assets as it is more likely than not that some or all of the Company’s deferred tax assets will not be realized.

The Company evaluates its tax positions on a quarterly basis and revises its estimate accordingly. There were no material changes to the Company’s uncertain tax positions, interest, or penalties during the three months ended March 31, 2023.

XML

Earnings (Loss) Per Share

3 Months Ended

Mar. 31, 2023

Earnings Per Share [Abstract]

Earnings (Loss) Per Share

15. Earnings (Loss) per Share

The computation of loss per share of Class A and Class X Common Stock is as follows (in thousands, except share and per share information):

	Three months ended March 31,
	2023			2022
Numerator:
Net loss	$	(29,188	)	$	(73,533	)
Denominator:
Weighted-average common shares outstanding, basic and diluted		309,140,558			306,362,730
Net loss per common share, basic and diluted	$	(0.09	)	$	(0.24	)

Basic net loss per common share is the same as dilutive net loss per common share for each of the three months ended March 31, 2023 and 2022 as the inclusion of all potential common shares would have been antidilutive.

The following table presents the common shares that are excluded from the computation of diluted net loss per common share as of the periods presented because including them would have been antidilutive:

	March 31,
	2023		2022
Options		48,108,932		38,674,077
RSUs		15,480,068		322,596
Compensation warrants		3,980,656		3,980,656
Public and private placement warrants		15,333,333		15,333,333
Term Loan warrants		4,716,756		—
Earn-out shares		3,750,000		3,750,000
		91,369,745		62,060,662

XML

Description Of Business And Summary Of Significant Accounting Policies (Polices)

3 Months Ended

Mar. 31, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation and Principles of Consolidation

Basis of Presentation and Principles of Consolidation

The Company prepares its consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information as determined by the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) and pursuant to the regulations of the U.S. Securities and Exchange Commission (“SEC”).

The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that impact the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Significant estimates include, but are not limited to, the useful life and recoverability of long-lived assets, the valuation of warrant liabilities, the recognition and measurement of income tax assets and liabilities, the valuation of intangible assets, impairment of goodwill, and the net realizable value of inventory. The Company bases these estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgements about the carrying amounts of assets and liabilities. Actual results could differ from those estimates.

The unaudited condensed consolidated financial statements have been prepared on the same basis as the annual audited consolidated financial statements and, in the opinion of management, include all normal recurring adjustments necessary for the fair statement of the Company’s financial position, results of operations, and cash flows. The financial data and other financial information disclosed in the notes to these unaudited condensed consolidated financial statements are also unaudited. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the related notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. Interim results are not necessarily indicative of the results expected for the full fiscal year or any other period.

Recently Adopted Accounting Pronouncements

Recently Adopted Accounting Pronouncements

In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which requires an acquirer to apply ASC 606 to recognize and measure contract assets and liabilities from contracts with customers acquired in a business combination on the acquisition date rather than the general guidance in ASC 805. The Company adopted this new accounting guidance on a prospective basis on January 1, 2023, and the adoption did not have a material effect on its unaudited condensed consolidated financial statements.

In September 2022, the FASB issued ASU 2022-04, Liabilities-Supplier Finance Programs (Topic 405-50) - Disclosure of Supplier Finance Program Obligations, which requires that a buyer in a supplier finance program disclose sufficient information about the program to allow a user of financial statements to understand the program’s nature, activity during the period, changes from period to period, and potential magnitude. The Company adopted this new accounting guidance on a prospective basis on January 1, 2023, and the adoption did not have a material effect on its unaudited condensed consolidated financial statements.

XML

Revenue (Tables)

3 Months Ended

Mar. 31, 2023

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenue

The Company’s revenue disaggregated by geographic region is as follows (in thousands):

	Three months ended March 31,
	2023		2022
Geographic region:
United States	$	130,877	$	178,607
Rest of world1		14,024		20,315
Total revenue	$	144,901	$	198,922

(1) Consists of Canada, United Kingdom, and France. No single country accounted for more than 10% of total revenue during the three months ended March 31, 2023 and 2022.

XML

Fair Value Measurements (Tables)

3 Months Ended

Mar. 31, 2023

Fair Value Disclosures [Abstract]

Summary of Fair Value Measurements, Recurring and Nonrecurring

The Company’s financial assets and liabilities subject to fair value measurements on a recurring basis and the level of inputs used for such measurements were as follows (in thousands):

	March 31, 2023
	Level 1		Level 2		Level 3
Assets
Derivative assets	$	—	$	249	$	—
Total assets	$	—	$	249	$	—
Liabilities
Public warrants	$	600	$	—	$	—
Private placement warrants		—		—		53
Term Loan warrants		—		—		1,038
Total liabilities	$	600	$	—	$	1,091
	December 31, 2022
	Level 1		Level 2		Level 3
Assets
Derivative assets	$	—	$	462	$	—
Total assets	$	—	$	462	$	—
Liabilities
Public Warrants	$	415	$	—	$	—
Private Placement Warrants		—		—		107
Term Loan Warrants		—		—		1,226
Total liabilities	$	415	$	—	$	1,333

Summary of Fair Value of Significant Assumptions Utilized in the Valuation

The following table presents significant assumptions utilized in the valuation of the private placement warrants on March 31, 2023 and December 31, 2022:

	March 31, 2023			December 31, 2022
Risk-free rate		3.8	%		4.2	%
Dividend yield rate		—			—
Volatility		75.0	%		75.0	%
Contractual term (in years)		3.24			3.49
Exercise price	$	11.50		$	11.50

The following table presents significant assumptions utilized in the valuation of the Term Loan Warrants at March 31, 2023 and December 31, 2022:

	March 31, 2023			December 31, 2022
Risk-free rate		3.6	%		4.0	%
Dividend yield rate		—			—
Volatility		75.0	%		75.0	%
Contractual term (in years)		6.36			6.61
Exercise price	$	1.85		$	1.85

Summary of Change in the Fair Value of the Warrants

The following table presents changes in the fair value of the private placement warrants for the three months ended March 31, 2023 and 2022 (in thousands):

	Three months ended March 31,
	2023			2022
Balance, beginning of period	$	107		$	2,133
Change in fair value		(54	)		(213	)
Balance, end of period	$	53		$	1,920

The following table presents changes in the fair value of the Term Loan warrants for the three months ended March 31, 2023 and 2022 (in thousands):

	Three months ended March 31,
	2023			2022
Balance, beginning of period	$	1,226		$	—
Change in fair value		(188	)		—
Balance, end of period	$	1,038		$	—

XML

Inventory, Net (Tables)

3 Months Ended

Mar. 31, 2023

Inventory Disclosure [Abstract]

Schedule of Inventory, Current

Inventory, net consists of the following (in thousands):

	March 31, 2023		December 31, 2022
Raw materials and work in process	$	12,620	$	13,380
Finished goods		35,684		40,680
Total inventory, net	$	48,304	$	54,060

XML

Other Current Assets (Table)

3 Months Ended

Mar. 31, 2023

Other Current Assets [Abstract]

Summary of Other Current Assets

Other current assets consist of the following (in thousands):

	March 31, 2023		December 31, 2022
Deferred partner costs	$	35,301	$	31,270
Deposits		5,876		4,527
Accounts receivable, net		1,839		866
Other		2,671		2,585
Total other current assets	$	45,687	$	39,248

XML

Property and equipment, Net (Tables)

3 Months Ended

Mar. 31, 2023

Property, Plant and Equipment [Abstract]

Summary of Property and equipment, net

Property and equipment, net consists of the following (in thousands):

	March 31, 2023			December 31, 2022
Computer software and web development	$	224,851		$	236,533
Computer equipment		23,452			24,240
Buildings		5,158			5,158
Leasehold improvements		4,600			4,600
Furniture, fixtures and equipment		1,207			1,222
Computer software and web development projects in-process		7,028			5,147
Property and equipment, gross		266,296			276,900
Less: Accumulated depreciation		(198,901	)		(202,753	)
Total property and equipment, net	$	67,395		$	74,147

Summary of depreciation expense related to property and equipment

The Company recorded depreciation expense related to property and equipment in the following expense categories of its unaudited condensed consolidated statements of operations as follows (in thousands):

	Three months ended March 31,
	2023		2022
Cost of revenue	$	4,932	$	9,081
Selling and marketing		—		279
Enterprise technology and development		4,503		7,449
General and administrative		1		192
Total depreciation	$	9,436	$	17,001

XML

Accrued Expenses (Tables)

3 Months Ended

Mar. 31, 2023

Payables and Accruals [Abstract]

Summary of Accrued Expenses

Accrued expenses consist of the followings (in thousands):

	March 31, 2023		December 31, 2022
Inventory, shipping and fulfillment	$	13,233	$	11,687
Partner costs		13,047		14,535
Employee compensation and benefits		10,610		20,584
Sales and other taxes		4,891		4,818
Information technology		2,545		2,207
Advertising		1,773		1,176
Customer service expenses		790		956
Other accrued expenses		7,895		8,467
Total accrued expenses	$	54,784	$	64,430

XML

Commitments and Contingencies (Tables)

3 Months Ended

Mar. 31, 2023

Purchase Obligation, Fiscal Year Maturity [Abstract]

Summary of Purchase Obligation, Fiscal Year Maturity

Future minimum payments under noncancelable service and inventory purchase agreements for the periods succeeding March 31, 2023 are as follows (in thousands):

Nine months ending December 31, 2023	$	26,651
Year ending December 31, 2024		2,039
Year ending December 31, 2025		1,475
Year ending December 31, 2026		100
Year ending December 31, 2027		75
Thereafter		75
	$	30,415

XML

Debt (Tables)

3 Months Ended

Mar. 31, 2023

Debt Disclosure [Abstract]

Schedule of Aggregate Amounts of Payments Due and Reconciliation of Debt Balances, Net of Debt Discount and Debt Issuance Costs

The aggregate amounts of payments due for the periods succeeding March 31, 2023 and reconciliation of the Company’s debt balances, net of debt discount and debt issuance costs, are as follows (in thousands):

Nine months ending December 31, 2023	$	937
Year ending December 31, 2024		1,563
Year ending December 31, 2025		2,500
Year ending December 31, 2026		44,063
Total debt	$	49,063
Less current portion		(1,250	)
Less unamortized debt discount and debt issuance costs		(8,509	)
Add capitalized paid-in-kind interest		972
Total long-term debt	$	40,276

XML

Stockholders' Equity (Tables)

3 Months Ended

Mar. 31, 2023

Stockholders' Equity Note [Abstract]

Summarize Changes in Accumulated Other Comprehensive Income (Loss)

The following tables summarize changes in accumulated other comprehensive income (loss) by component during the three months ended March 31, 2023 and 2022 (in thousands):

	Unrealized Gain (Loss) on Derivatives			Foreign Currency Translation Adjustment			Total
Balances at December 31, 2021	$	(32	)	$	11		$	(21	)
Other comprehensive loss before reclassifications		(162	)		4			(158	)
Amounts reclassified from accumulated other comprehensive income (loss)		69			—			69
Tax effect		(23	)		—			(23	)
Balances at March 31, 2022	$	(148	)	$	15		$	(133	)
Balances at December 31, 2022	$	131		$	(94	)	$	37
Other comprehensive loss before reclassifications		(101	)		10			(91	)
Amounts reclassified from accumulated other comprehensive income (loss)		(87	)		—			(87	)
Tax effect		(46	)		—			(46	)
Balances at March 31, 2023	$	(103	)	$	(84	)	$	(187	)

XML

Equity-Based Compensation (Tables)

3 Months Ended

Mar. 31, 2023

Schedule of Share Based Compensation Activity [Abstract]

Summary of the Option Activity under the Equity Compensation Plans

A summary of the option activity under the Company’s equity compensation plans is as follows:

	Options Outstanding
	Number of Options			Weighted-Average Exercise Price (per option)		Weighted-Average Remaining Contractual Term (in years)		Aggregate Intrinsic Value (in thousands)
Outstanding at December 31, 2022		48,414,625		$	2.65		6.35	$	—
Granted		3,463,488			0.63
Forfeited		(3,272,682	)		2.80
Expired		(496,499	)		2.54
Outstanding at March 31, 2023		48,108,932		$	2.49		5.91	$	—
Exercisable at March 31, 2023		23,015,721		$	2.48		2.86	$	—

Summary of RSU Activity

A summary of RSU activity is as follows:

	RSUs Outstanding
	Number of RSUs			Weighted-Average Fair Value (per RSU)
Outstanding at December 31, 2022		3,159,185		$	1.45
Granted		22,676,189			0.58
Vested		(9,736,133	)		0.60
Forfeited		(619,173	)		0.96
Outstanding at March 31, 2023		15,480,068		$	0.73

Summary of Assumptions Used to Determine the Fair Value of Option Grants

The fair value of each award as of the date of grant is estimated using a Black-Scholes option-pricing model. The following table summarizes the weighted-average assumptions used to determine the fair value of option grants:

	Three months ended March 31,
	2023			2022
Risk-free rate		3.6	%		1.7	%
Dividend yield rate		—			—
Volatility		56.4	%		52.3	%
Expected term (in years)		5.16			6.20
Weighted-average grant date fair value	$	0.32		$	0.95

Summary of Equity-Based Compensation Expense

Equity-based compensation expense for the three months ended March 31, 2023 and 2022 was as follows (in thousands):

	Three months ended March 31,
	2023		2022
Cost of revenue	$	1,429	$	335
Selling and marketing		3,386		1,639
Enterprise technology and development		563		927
General and administrative		4,177		1,663
Total equity-based compensation	$	9,555	$	4,564

XML

Derivative Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2022

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Summary of Pre-Tax Effects of the Company's Derivative Instruments on its Unaudited Condensed Consolidated Statements of Operations

The following table shows the pre-tax effects of the Company’s derivative instruments on its unaudited condensed consolidated statements of operations (in thousands):

		Three months ended March 31,
	Financial Statement Line Item	2023			2022
Unrealized gains (losses)	Other comprehensive income (loss)	$	(101	)	$	(162	)
Gains (losses) reclassified from accumulated other	Cost of revenue	$	36		$	(30	)
comprehensive income into net loss	General and administrative		51			(39	)
Total amounts reclassified		$	87		$	(69	)
Gains (losses) recognized on derivatives   not designated as hedging instruments	Cost of revenue	$	(41	)	$	(51	)

XML

Restructuring (Tables)

3 Months Ended

Mar. 31, 2023

Restructuring and Related Activities [Abstract]

Summary of Restructuring Related Liability and Restructuring Costs Activity

The following table summarizes activity in the Company’s restructuring-related liability during the three months ended March 31, 2023 (in thousands):

	Balance at		Restructuring		Payments /			Liability at
	December 31, 2022		Charges		Utilizations			March 31, 2023
Employee-related costs	$	469	$	5,387	$	(4,467	)	$	1,389
Total costs	$	469	$	5,387	$	(4,467	)	$	1,389

XML

Earnings (Loss) Per Share (Tables)

3 Months Ended

Mar. 31, 2023

Earnings Per Share [Abstract]

Summary of the Computation of Loss Per Share of Class A and Class X Common Stock

The computation of loss per share of Class A and Class X Common Stock is as follows (in thousands, except share and per share information):

	Three months ended March 31,
	2023			2022
Numerator:
Net loss	$	(29,188	)	$	(73,533	)
Denominator:
Weighted-average common shares outstanding, basic and diluted		309,140,558			306,362,730
Net loss per common share, basic and diluted	$	(0.09	)	$	(0.24	)

Summary of Common Shares That Are Excluded From the Computation of Diluted Net Loss Per Common Share

The following table presents the common shares that are excluded from the computation of diluted net loss per common share as of the periods presented because including them would have been antidilutive:

	March 31,
	2023		2022
Options		48,108,932		38,674,077
RSUs		15,480,068		322,596
Compensation warrants		3,980,656		3,980,656
Public and private placement warrants		15,333,333		15,333,333
Term Loan warrants		4,716,756		—
Earn-out shares		3,750,000		3,750,000
		91,369,745		62,060,662

XML

Description Of Business And Summary Of Significant Accounting Policies - Additional Information (Details)	Mar. 31, 2023
ASU 2021-08 [Member]
Description Of Business And Summary Of Significant Accounting Policies [Line Items]
Change in accounting principle, accounting standards update, adopted [true false]	true
Change in accounting principle, accounting standards update adoption date	Jan. 01, 2023
Change in accounting principle, accounting standards update, immaterial effect [true false]	true
ASU 2022-04 [Member]
Description Of Business And Summary Of Significant Accounting Policies [Line Items]
Change in accounting principle, accounting standards update, adopted [true false]	true
Change in accounting principle, accounting standards update adoption date	Jan. 01, 2023
Change in accounting principle, accounting standards update, immaterial effect [true false]	true

XML

Revenue - Disaggregation of Revenue (Details) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2023	Mar. 31, 2022
Disaggregation of Revenue [Line Items]
Revenue		$ 144,901	$ 198,922
United States [Member]
Disaggregation of Revenue [Line Items]
Revenue		130,877	178,607
Rest of world [Member]
Disaggregation of Revenue [Line Items]
Revenue	[1]	$ 14,024	$ 20,315

[1] Consists of Canada, United Kingdom, and France. No single country accounted for more than 10% of total revenue during the three months ended March 31, 2023 and 2022.

XML

Revenue - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Deferred Revenue [Member]
Disaggregation of Revenue [Line Items]
Contract with customer liability, Current	$ 53.1	$ 62.5

XML

Fair Value Measurements - Summary of Fair Value Measurements, Recurring and Nonrecurring (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset, Statement of Financial Position [Extensible Enumeration]	Other Assets, Noncurrent	Other Assets, Noncurrent
Derivative Liability, Statement of Financial Position [Extensible Enumeration]	Other Liabilities, Noncurrent	Other Liabilities, Noncurrent
Fair Value, Recurring [Member] | Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total Liabilities	$ 600	$ 415
Fair Value, Recurring [Member] | Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset	249	462
Total Assets	249	462
Fair Value, Recurring [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total Liabilities	1,091	1,333
Fair Value, Recurring [Member] | Public Warrants [Member] | Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants	600	415
Fair Value, Recurring [Member] | Private Placement Warrants [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants	53	107
Fair Value, Recurring [Member] | Term Loan Warrants [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants	$ 1,038	$ 1,226

XML

Fair Value Measurements - Summary of Fair Value of Significant Assumptions Utilized in the Valuation (Details)	Mar. 31, 2023 yr	Dec. 31, 2022 yr
Private Placement Warrants [Member] | Risk-free Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value, Measurement Input	0.038	0.042
Private Placement Warrants [Member] | Dividend Yield Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value, Measurement Input	0	0
Private Placement Warrants [Member] | Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value, Measurement Input	0.750	0.750
Private Placement Warrants [Member] | Contractual Term (in years) [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value, Measurement Input	3.24	3.49
Private Placement Warrants [Member] | Exercise Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value, Measurement Input	11.50	11.50
Term Loan Warrants [Member] | Risk-free Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value, Measurement Input	0.036	0.040
Term Loan Warrants [Member] | Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value, Measurement Input	0.750	0.750
Term Loan Warrants [Member] | Contractual Term (in years) [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value, Measurement Input	6.36	6.61
Term Loan Warrants [Member] | Exercise Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value, Measurement Input	1.85	1.85

XML

Fair Value Measurements - Summary of Change in the Fair Value of the Warrants (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Private Placement Warrants [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance, beginning of period	$ 107	$ 2,133
Change in fair value	(54)	(213)
Balance, end of period	53	$ 1,920
Term Loan Warrants [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance, beginning of period	1,226
Change in fair value	(188)
Balance, end of period	$ 1,038

XML

Inventory, Net - Schedule of Inventory, Current (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Inventory, Net [Abstract]
Raw materials and work in process	$ 12,620	$ 13,380
Finished goods	35,684	40,680
Total inventory, net	$ 48,304	$ 54,060

XML

Inventory, Net - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Inventory [Line Items]
Inventory Write-down	$ 2.7	$ 16.9
Nutrition And Other [Member]
Inventory [Line Items]
Inventory Write-down	1.3	2.5
Connected Fitness [Member]
Inventory [Line Items]
Inventory Write-down	$ 1.4	$ 14.4

XML

Other Current Assets - Summary of Other Current Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Other Current Assets [Abstract]
Deferred partner costs	$ 35,301	$ 31,270
Deposits	5,876	4,527
Accounts receivable, net	1,839	866
Other	2,671	2,585
Total other current assets	$ 45,687	$ 39,248

XML

Property and Equipment, Net - Summary of Property and Equipment, Net (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 266,296	$ 276,900
Less: Accumulated depreciation	(198,901)	(202,753)
Total property and equipment, net	67,395	74,147
Computer software and web development [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	224,851	236,533
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	23,452	24,240
Building [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	5,158	5,158
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	4,600	4,600
Furniture, fixtures and equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	1,207	1,222
Computer Software and Web Development Projects In-process [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 7,028	$ 5,147

XML

Property and Equipment, Net - Summary of Depreciation Expense Related to Property and Equipment (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Schedule of depreciation expense related to property and equipment [Line Items]
Depreciation	$ 9,436	$ 17,001
Cost of Revenue [Member]
Schedule of depreciation expense related to property and equipment [Line Items]
Depreciation	4,932	9,081
Selling and Marketing [Member]
Schedule of depreciation expense related to property and equipment [Line Items]
Depreciation		279
Enterprise Technology and Development [Member]
Schedule of depreciation expense related to property and equipment [Line Items]
Depreciation	4,503	7,449
General and Administrative [Member]
Schedule of depreciation expense related to property and equipment [Line Items]
Depreciation	$ 1	$ 192

XML

Accrued Expenses - Summary of Accrued Expenses (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Payables and Accruals [Abstract]
Inventory, shipping and fulfillment	$ 13,233	$ 11,687
Partner costs	13,047	14,535
Employee compensation and benefits	10,610	20,584
Sales and other taxes	4,891	4,818
Information technology	2,545	2,207
Advertising	1,773	1,176
Customer service expenses	790	956
Other accrued expenses	7,895	8,467
Total accrued expenses	$ 54,784	$ 64,430

XML

Accrued Expenses - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Payables and Accruals [Abstract]
Advertising costs	$ 9.0	$ 15.8

XML

Commitments and Contingencies - Additional Information (Details) $ in Millions	3 Months Ended
	Mar. 31, 2023 USD ($)
Product Liability Contingency [Line Items]
Operating lease expiring term	leases facilities under noncancelable operating leases expiring through 2027
Finance lease expiring term	certain equipment under a finance lease expiring in 2024.
Payments during the nine months ending December 31, 2023	$ 1.8
Payments in 2024	3.6
Payments in 2025	3.6
Payments in 2026	3.6
Payments in 2027	$ 3.6

XML

Commitments and Contingencies - Summary of Purchase Obligation, Fiscal Year Maturity (Details) $ in Thousands	Mar. 31, 2023 USD ($)
Purchase Obligation, Fiscal Year Maturity [Abstract]
Nine months ending December 31, 2023	$ 26,651
Year ending December 31, 2024	2,039
Year ending December 31, 2025	1,475
Year ending December 31, 2026	100
Year ending December 31, 2027	75
Thereafter	75
Purchase Obligation	$ 30,415

XML

Debt - Additional Information (Details) - USD ($)		3 Months Ended
	Aug. 08, 2022	Mar. 31, 2023	Mar. 31, 2022
Debt Instrument [Line Items]
Borrowings outstanding		$ 49,063,000
Interest expense		2,331,000	$ 19,000
Term Loan [Member]
Debt Instrument [Line Items]
Credit line	$ 50,000,000.0
Borrowings outstanding		$ 49,100,000
Debt instrument, maturity date		Aug. 08, 2026
Percentage of interest rate during period	2.00%
Interest expense		$ 2,300,000
Third-party debt issuance costs	$ 4,200,000
Warrants vesting percentage first year	30.00%
Warrants vesting percentage second year	30.00%
Warrants vesting percentage third year	20.00%
Warrants vesting percentage fourth year	20.00%
Warrants and rights outstanding, term	7 years
Fair value of warrant liabilities	$ 5,200,000
Percentage of annual amortization, first year	2.50%
Percentage of annual amortization, second year	2.50%
Percentage of annual amortization, thereafter	5.00%
Annual amortization, periodic payment	quarterly
Financial covenants, minimum revenue required till June 30, 2023		12,500,000
Financial covenants, minimum revenue required, thereafter till maturity		$ 15,000,000.0
Term Loan [Member] | Common Class A [Member]
Debt Instrument [Line Items]
Number of warrants issued	4,716,756
Class of warrants or rights exercise price per share	$ 1.85
Term Loan [Member] | Secured Overnight Financing Rate [Member]
Debt Instrument [Line Items]
Credit line	$ 50,000,000.0
Percentage of interest rate on agreement	6.15%
Percentage of interest rate during period	7.15%
Debt instrument, cash interest rate	12.03%
Percentage of interest paid in kind	3.00%
Term Loan [Member] | Secured Overnight Financing Rate [Member] | Floor Rate [Member]
Debt Instrument [Line Items]
Percentage of interest rate during period	1.00%
Term Loan [Member] | Federal Funds Rate [Member]
Debt Instrument [Line Items]
Percentage of interest rate during period	0.50%
Term Loan [Member] | One Month SOFR [Member]
Debt Instrument [Line Items]
Percentage of interest rate during period	1.00%
Term Loan [Member] | Maximum [Member]
Debt Instrument [Line Items]
Line of credit facility, additional amount of incremental facility	$ 25,000,000.0

XML

Debt - Schedule of Aggregate Amounts of Payments Due and Reconciliation of Debt Balances, Net of Debt Discount and Debt Issuance Costs (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Debt Disclosure [Abstract]
Nine months ending December 31, 2023	$ 937
Year ending December 31, 2024	1,563
Year ending December 31, 2025	2,500
Year ending December 31, 2026	44,063
Total debt	49,063
Less current portion	(1,250)	$ (1,250)
Less unamortized debt discount and debt issuance costs	(8,509)
Add capitalized paid-in-kind interest	972
Total long-term debt	$ 40,276	$ 39,735

XML

Stockholders' Equity - Additional Information (Details) - $ / shares	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Number of shares authorized	2,000,000,000
Par value of shares authorized	$ 0.0001
Common stock, shares authorized	1,900,000,000	1,900,000,000
Preferred stock, shares authorized	100,000,000	100,000,000
Common stock shares voting rights	The holder of each Class A Common Stock is entitled to one vote, the holder of each share of Class X Common Stock is entitled to ten votes and except as otherwise required by law, the holder of each share of Class C Common Stock is not entitled to any voting powers.
Common Class A [Member]
Common stock, shares authorized	1,600,000,000	1,600,000,000
Common stock shares voting rights	one vote
Common Class C [Member]
Common stock, shares authorized	100,000,000	100,000,000
Common Class X [Member]
Common stock, shares authorized	200,000,000
Common stock shares voting rights	ten votes

XML

Stockholders' Equity - Summarize Changes in Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Stockholders' Equity Note [Abstract]
Unrealized Gain (Loss) on Derivatives, Balances at Beginning	$ 131	$ (32)
Unrealized Gain (Loss) on Derivatives, Other comprehensive loss before reclassifications	(101)	(162)
Unrealized Gain (Loss) on Derivatives, Amounts reclassified from accumulated other comprehensive income (loss)	87	(69)
Unrealized Gain (Loss) on Derivatives, Tax effect	(46)	(23)
Unrealized Gain (Loss) on Derivatives, Balance at Ending	(103)	(148)
Foreign Currency Translation Adjustment, Balances at Beginning	(94)	11
Foreign Currency Translation Adjustment, Other comprehensive loss before reclassifications	10	4
Foreign Currency Translation Adjustment, Balance at Ending	(84)	15
Balances at Beginning	37	(21)
Other comprehensive loss before reclassifications	(91)	(158)
Amounts reclassified from accumulated other comprehensive income (loss)	(87)	69
Tax effect	(46)	(23)
Balance at Ending	$ (187)	$ (133)

XML

Equity-Based Compensation - Additional Information (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2023 USD ($) Employee shares	Mar. 31, 2022 USD ($)	Jan. 01, 2023 shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Unrecognized equity-based compensation expense	$ 38,800
Payment, fair value of tax withholding and remitted taxes share-based payment arrangement		$ 192
Weighted-average remaining period	2 years 10 months 17 days
Number of terminated employees stock awards modified | Employee	102
General and Administrative Expense [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Reduction in equity-based compensation cost recognized	$ 600
2021 Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-based compensation number of shares available for grant | shares	11,663,071
Payment, fair value of tax withholding and remitted taxes share-based payment arrangement	$ 2,100
Maximum [Member] | 2021 Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-based compensation number of shares available for grant | shares			15,608,106
RSUs [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Fair value of RSU, vested	$ 5,900	$ 0

XML

Equity-Based Compensation - Summary of the Option Activity under the Equity Compensation Plans (Details) - 2021 Plan [Member] - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Schedule of Share Based Compensation Activity [Line Items]
Number of Options, Outstanding Beginning	48,414,625
Number of Options, Granted	3,463,488
Number of Options, Forfeited	(3,272,682)
Number of Options, Expired	(496,499)
Number of Options, Outstanding Ending	48,108,932	48,414,625
Number of Options, Exercisable	23,015,721
Weighted- Average Exercise Price (per option), Outstanding Beginning	$ 2.65
Weighted- Average Exercise Price (per option), Granted	0.63
Weighted- Average Exercise Price (per option), Forfeited	2.80
Weighted- Average Exercise Price (per option), Expired	2.54
Weighted- Average Exercise Price (per option), Outstanding Ending	2.49	$ 2.65
Weighted- Average Exercise Price (per option), Exercisable	$ 2.48
Weighted- Average Remaining Contractual Term (in years), Outstanding	5 years 10 months 28 days	6 years 4 months 6 days
Weighted- Average Remaining Contractual Term (in years), Exercisable	2 years 10 months 9 days

XML

Equity-Based Compensation - Summary of RSU Activity (Details) - Restricted Stock Units (RSUs) [Member]	3 Months Ended
	Mar. 31, 2023 $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of RSUs, Outstanding Beginning | shares	3,159,185
Number of RSUs, Granted | shares	22,676,189
Number of RSUs, Vested | shares	(9,736,133)
Number of RSUs, Forfeited | shares	(619,173)
Number of RSUs, Outstanding Ending | shares	15,480,068
Weighted Average Fair Value (per RSU), Outstanding Beginning | $ / shares	$ 1.45
Weighted Average Fair Value (per RSU), Granted | $ / shares	0.58
Weighted-Average Fair Value (per RSU), Vested | $ / shares	0.60
Weighted-Average Fair Value (per RSU), Forfeited | $ / shares	0.96
Weighted Average Fair Value (per RSU), Outstanding Ending | $ / shares	$ 0.73

XML

Equity-Based Compensation - Summary of Assumptions Used to Determine the Fair Value of Option Grants (Details) - $ / shares	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Risk-free rate	3.60%	1.70%
Dividend yield rate	0.00%	0.00%
Volatility	56.40%	52.30%
Expected term (in years)	5 years 1 month 28 days	6 years 2 months 12 days
Weighted-average grant date fair value	$ 0.32	$ 0.95

XML

Equity-Based Compensation - Summary of Equity-Based Compensation Expense - Summary of Equity-Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Schedule of Compensation Cost for Share Based Payment Arrangements Allocation of Share Based Compensation Costs by Plan [Line Items]
Equity-based compensation	$ 9,555	$ 4,564
Cost of Revenue [Member]
Schedule of Compensation Cost for Share Based Payment Arrangements Allocation of Share Based Compensation Costs by Plan [Line Items]
Equity-based compensation	1,429	335
Selling and Marketing [Member]
Schedule of Compensation Cost for Share Based Payment Arrangements Allocation of Share Based Compensation Costs by Plan [Line Items]
Equity-based compensation	3,386	1,639
Enterprise Technology and Development [Member]
Schedule of Compensation Cost for Share Based Payment Arrangements Allocation of Share Based Compensation Costs by Plan [Line Items]
Equity-based compensation	563	927
General and Administrative [Member]
Schedule of Compensation Cost for Share Based Payment Arrangements Allocation of Share Based Compensation Costs by Plan [Line Items]
Equity-based compensation	$ 4,177	$ 1,663

XML

Derivative Financial Instruments - Additional Information (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Foreign Exchange Option [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative asset, notional amount	$ 16,700	$ 17,600
Foreign Exchange Forward [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative asset, notional amount	$ 0	$ 0

XML

Derivative Financial Instruments - Summary of Pre-Tax Effects of the Company's Derivative Instruments on its Unaudited Condensed Consolidated Statements of Operations (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Gains (losses) recognized on derivatives not designated as hedging instruments	$ (91)	$ (158)
Total amounts reclassified	87	(69)
Foreign Currency Hedges [Member]
Total amounts reclassified	87	(69)
Foreign Currency Hedges [Member] | Cost of Revenue [Member]
Gains (losses) recognized on derivatives not designated as hedging instruments	(41)	(51)
Total amounts reclassified	36	(30)
Foreign Currency Hedges [Member] | General and Administrative [Member]
Total amounts reclassified	51	(39)
Foreign Currency Hedges [Member] | Other comprehensive income (loss) [Member]
Gains (losses) recognized on derivatives not designated as hedging instruments	$ (101)	$ (162)

XML

Restructuring - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Restructuring Cost and Reserve [Line Items]
Restructuring costs	$ 5,400	$ 7,200
Termination benefit related to headcount reductions	1,389		$ 469
Additional charges related to termination benefits	$ 200

XML

Restructuring - Summary of Restructuring Related Liability and Restructuring Costs Activity (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2023 USD ($)
Restructuring Cost and Reserve [Line Items]
Balance, beginning of period	$ 469
Restructuring Charges	5,387
Payments / Utilizations	(4,467)
Balance, end of period	1,389
Employee-Related Costs
Restructuring Cost and Reserve [Line Items]
Balance, beginning of period	469
Restructuring Charges	5,387
Payments / Utilizations	(4,467)
Balance, end of period	$ 1,389

XML

Income Taxes - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Tax Disclosure [Abstract]
Income tax (provision) benefit	$ (48)	$ 706
Effective benefit tax rate	(0.20%)	1.00%

XML

Earnings (Loss) Per Share - Summary of the Computation of Loss Per Share of Class A and Class X Common Stock (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Numerator:
Net loss	$ (29,188)	$ (73,533)
Denominator:
Weighted-average common shares outstanding, basic	309,140,558	306,362,730
Weighted-average common shares outstanding, diluted	309,140,558	306,362,730
Net loss per common share, basic	$ (0.09)	$ (0.24)
Net loss per common share, diluted	$ (0.09)	$ (0.24)

XML

Earnings (Loss) Per Share - Summary of Common Shares That Are Excluded From the Computation of Diluted Net Loss Per Common Share (Details) - shares	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	91,369,745	62,060,662
Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	48,108,932	38,674,077
RSUs [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	15,480,068	322,596
Compensation Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	3,980,656	3,980,656
Public and Private Placement Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	15,333,333	15,333,333
Term Loan Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	4,716,756
Earn-out Shares [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	3,750,000	3,750,000